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Abstract:  Ciguatera  fish  poisoning  (CFP)  occurs  mainly  when  humans  ingest  finfish 
contaminated with ciguatoxins (CTXs). The complexity and variability of such toxins have 
made it difficult to develop reliable methods to routinely monitor CFP with specificity and 
sensitivity. This review aims to describe the methodologies available for CTX detection, 
including  those  based  on  the  toxicological,  biochemical,  chemical,  and  pharmaceutical 
properties  of  CTXs.  Selecting  any  of  these  methodological  approaches  for  routine 
monitoring of ciguatera may be dependent upon the applicability of the method. However, 
identifying a reference validation method for CTXs is a critical and urgent issue, and is 
dependent upon the availability of certified CTX standards and the coordinated action of 
laboratories. Reports of CFP cases in European hospitals have been described in several 
countries, and are mostly due to travel to CFP endemic areas. Additionally, the recent 
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detection  of  the  CTX-producing  tropical  genus  Gambierdiscus  in  the  eastern  Atlantic 
Ocean  of  the  northern  hemisphere  and  in  the  Mediterranean  Sea,  as  well  as  the 
confirmation  of  CFP  in  the  Canary  Islands  and  possibly  in  Madeira,  constitute  other 
reasons to study the onset of CFP in Europe [1]. The question of the possible contribution 
of climate change to the distribution of toxin-producing microalgae and ciguateric fish is 
raised. The impact of ciguatera onset on European Union (EU) policies will be discussed 
with  respect  to  EU  regulations  on  marine  toxins  in  seafood.  Critical  analysis  and 
availability of methodologies for CTX determination is required for a rapid response to 
suspected CFP cases and to conduct sound CFP risk analysis. 
Keywords:  ciguatera;  CFP;  ciguatoxin;  detection  methods;  Gambierdiscus;  methods; 
Europe 
 
1. Introduction 
Ciguatera Fish Poisoning (CFP) is a human intoxication caused by the consumption of fish that 
contain ciguatoxins (CTXs) [2]. The geographical distribution of CFP occurrence is mainly limited to 
tropical and subtropical areas. CFP is found endemically within the western Atlantic Ocean (including 
the Caribbean Sea), in the Indian Ocean, and in the Pacific [3]. Symptoms of the intoxication are used 
to diagnose and distinguish CFP from other seafood intoxications. However, the confirmation of cases 
of CFP relies upon the detection of CTXs in the remaining meal or within the plasma of patients [4]. 
Therefore, it is important to have adequate CTX quantification methods to diagnose CFP cases and 
moreover, to prevent intoxications through the analysis of consumable fish.  
CTXs  are  secondary  metabolites  produced  by  the  marine  benthic  dinoflagellate  of  the  genus 
Gambierdiscus. Numerous congeners of CTXs have been identified according to differences in their 
molecular  structure.  CTXs  from  distinct  geographical  origins  (e.g.,  Pacific,  Caribbean,  and  Indian 
CTXs) have been described. Some CTXs are transmitted through metabolism in the food chain. The 
high toxicity and diversity of CTXs, along with their presence at trace levels in fish tissue, make their 
reliable  detection  and  quantification  in  fish  flesh  difficult.  Numerous  methodologies  based  upon 
different  approaches  (e.g.,  toxicological  symptoms,  antibody  recognition,  mass  spectrometry,  etc.) 
have been developed for CTX recognition. Their applicability not only depends on the sensitivity and 
specificity of the method (ideally, the method is sensitive to all CTX congeners), but also relies on 
effective extraction and clean-up procedures, which are necessary to prepare samples for analysis. In 
the present review, a selection of protocols for sample preparation prior to the application of different 
methodologies of CTX determination is described. A revision of the different approaches available for 
CTX determination, i.e., in vivo mouse bioassay (MBA), in vitro cell based assays (CBA), competitive 
receptor binding assay (RBA), immunological analysis, and physicochemical analysis (HPLC), are 
further described. The applications of these assays as routine screening tools of CTXs in fish and 
Gambierdiscus spp. samples are also discussed.  
The interest for CFP in Europe has been increasing during the last years as CFP has been reported 
in the hospitals of Europe (e.g., France, Spain, the Netherlands, Germany, and Italy), usually in people Mar. Drugs 2010, 8 
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who consumed imported ciguateric fish or who travelled to CFP areas [5–8]. Recent reports indicate 
that  CFP  is  present  in  areas  of  Africa  close  to  Europe.  In  2004,  CFP  was  first  confirmed  after 
consumption of flesh from fish caught in the Canary Islands [9]. The presence of CTXs was also 
suspected  in  fish  from  Madeira  in  2007  and  2008  [10].  Additionally,  identification  of  species  of 
dinoflagellates of the genus Gambierdiscus, which are potential CTX producers, has been recorded in 
the Mediterranean Sea since 2003 [11–14], and for the first time in the waters of the Canary Islands in 
2004 [15]. 
Extensive reviews on CFP provide comprehensive analyses regarding the importance of CFP and 
the different factors that influence it [2,3,16–24]. The present review gives priority to two subjects. 
First, as introduced before, there is a review of CTX determination methods, so as to update readers of 
the  available  strategies  that  may  improve  in  the  future,  and  also  to  standardize and  prioritize  the 
appropriate methods for CFP management worldwide. Second, in light of the onset of CFP in Europe, 
the paper addresses the importance of the present evidence concerning the onset and evaluates possible 
measures to confront this potential crisis. In a context where the importance of CFP may be recognized 
world-wide, and considering the possible increase of CFP cases in traditionally non-endemic areas in 
Europe  and  elsewhere,  it  becomes  clear  that  CFP  risk  analysis  has  to  be  improved  to  reduce  
CFP impact.  
2. General Considerations about CFP 
2.1. Origin of CFP and toxic fish 
The food chain hypothesis, which suggests that the transfer of toxins along the food web is an 
explanation  for  CFP  movement,  was  first  proposed  by  Mills.  Mills  postulated  a  role  for  the 
phytoplankton in toxin synthesis [25]. This implication was later supported by Randall [26]. Further 
confirmation arrived by isolation of a toxic marine benthic dinoflagellate, posteriorly described as 
Gambierdiscus  toxicus;  it  was  seen  as  a  likely  source  of  CTXs  [27].  Adachi  and  Fukuyo  [28] 
confirmed that wild and cultured G. toxicus produce precursors of CTXs (known as gambiertoxins) 
[29]. Transfer of CTXs along the food web was suggested to start with dinoflagellates before moving 
on to herbivorous grazing fish, and then to the carnivorous fish that fed upon the grazers [30]. Some of 
these  toxins  accumulate  in  the  fish  tissue  and  can  be  metabolized  into  the  different  forms  (e.g.,  
CTX-1B and 51-hydroxyCTX-3C) from original CTX structures (e.g., CTX-3C and CTX-4B) that are 
ultimately responsible for human intoxication. 
Both herbivorous and carnivorous fish from tropical areas can be toxic. More than 400 fish species 
have been reported to be potentially ciguateric [31]. In several areas, it has been possible to recognize 
the  most  hazardous  fish  species.  For  example,  in  some  parts  of  the  Caribbean  Sea,  barracuda 
(Sphyraena spp.) are considered extremely hazardous CFP vectors. Identifying fish species at risk is 
certainly  useful  for  fisheries  management  and  for  the  establishment  of  public  health  regulations. 
However it is not possible to generalize and establish a list of hazardous species worldwide; there is 
significant  variation  in  toxin  content  between  individuals  within  the  same  species  and  between 
geographic areas. A general consideration in a given CFP endemic area is that within the same species, 
young fish are less hazardous than the older and larger ones. A shorter lifespan means a shorter time Mar. Drugs 2010, 8 
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span available for toxin accumulation in fish tissue. Oshiro et al. [32] stated that the toxicity of larger 
fish is higher than that of smaller ones. Additionally, carnivorous fish, and those situated at higher 
trophic  levels  within  the  food  webs,  can  be  considered  riskier  than  those  situated  at lower levels 
(herbivorous). However, these notions have been questioned by Darius et al. [33], who described no 
clear relationship between the size and weight of fish in samples from French Polynesia and CFP 
levels.  The  group  also  observed  that  herbivorous  fish  were  key  vectors  of  CFP  [34].  CFP  toxins 
accumulate mainly in the viscera of fish, but are also present in the muscle and other parts of the body 
[31,35]. Furthermore, it is important to distinguish fish involved in CFP from fish involved in other 
forms of poisoning (e.g., ichtyosarcotoxaemias) for which the causative agents and symptoms are 
different.  This  is  the  case  for  pufferfish  poisoning  (caused  by  tetrodotoxin),  scombromoid  fish 
poisoning (histamine), clupeoid poisoning, elasmobranch poisoning, mercury fish poisoning [36], or 
caulerpa poisoning [37]. 
2.2. Epidemiology and symptomatology 
The epidemiology of CFP is difficult to assess accurately since it is widely recognized that CFP 
cases  are  underreported  [38].  Still,  numerous  epidemiological  data  exists  on  CFP  [39–43].  It  is 
important to state that significant differences in symptoms may exist between patients. Differences 
also  exist  among  symptoms  presented  by  patients  from  distinct  geographical  areas  [44].  These 
differences are most probably due to structure-activity and pharmacokinetic variations encountered 
between the different CTX congeners [45,46]. Even within areas, the risk of CFP is not homogenous, 
and the incidence of CFP varies.  
About 400 million people live in areas where CFP is present. In 1998, the worldwide incidence of 
ciguatera was estimated to affect annually between 50,000 and 500,000 individuals [19,47]. CFP is 
rarely fatal with fatalities estimated to be <0.1%; however, fatalities may be higher in the Indian Ocean 
[48]. A survey from 2000 to 2008 in French Polynesia reported a mean incidence rate of around  
23 ±  6.5 cases per 10,000 per year [34]. The highest incidence rate was recorded at 464 cases per 
10,000 in 2002 in Raivavae Island [34]. Among the 47 fish species implicated as responsible in French 
Polynesia, most were carnivorous (68%), followed by herbivorous (21.3%), and omnivorous (10.3%) 
species [43]. In New Caledonia, a survey among the population showed that 70% of the population had 
experienced  CFP  [49].  A  recent  survey  conducted  in  2005  in  Noumé a  suggested  that  the  CFP 
prevalence  rate  even  increased  from  25%  in  1992  to  37.6%  in  2005  [50].  The  fish  species  most 
incriminated  in  CFP  cases  were  carnivorous  (85%)  [51],  followed  by  herbivorous  species. 
Additionally, four cases were related to shellfish consumption [50]. 
Clinical manifestations appear 2–30 h after consumption of ciguateric fish. The symptomatology of 
CFP is quite complex; there are many toxicological manifestations at different levels. The symptoms 
of CFP involve general (e.g., weakness, joint pains, back stiffness, myalgia, headache, chills, faintness, 
dizziness, oliguria, and itching), digestive (e.g., nausea, vomiting, diarrhea, abdominal pain, cramps, 
and dehydration), cardiovascular (e.g., low arterial pressure, irregular heartbeat, and bradycardia), and 
neurological (e.g., dysaesthesia, temperature reversal, paresthesia, superficial hyperesthesia, mydriasis, 
and absence of the patellar and achillean reflex) pathologies [26,39,52]. Some neurological symptoms 
are characteristic of CFP, such as dysaesthesia (reversal of cold and hot sensation/hypersensitivity to Mar. Drugs 2010, 8 
 
1842 
cold) and paresthesia (lack of sensitivity in the extremities). CFP neurological effects can also last for 
months,  and  occasionally,  years  [38,53].  Alcohol  consumption,  tobacco  smoking,  and  fish 
consumption have been shown to promote or reactivate symptoms [53,54]. According to numerous 
case studies and reports, the intravenous injection of mannitol (1 g kg
-1 over 30 min) early after CFP 
seems  to  be  the  most  efficient  therapy  for  CFP  [36,55,56].  Other  palliative  treatments  for  CFP 
intoxication have been implemented with some success, such as a a mixture of vitamins (C and B) and 
calcium gluconate in glucose solution [57], and other treatments oriented towards the mitigation or 
reversion of specific symptoms [36,58,59]. Folk remedies have been traditionally used to prevent or 
treat CFP-associated symptoms [60]. For instance, in a study by Boydron-Le Garrec et al. [61], 27 
plant extracts from 31 plants tested showed in vitro protective effects against CTX action, thus leading 
to the possible isolation of new bioactive compounds that can treat CFP [62]. Recently, brevenal, a 
polyether compound produced by the dinoflagellate Karenia brevis, was described as a potent inhibitor 
of  CTX-induced  neurotoxic  effects;  acting  through  the  inhibition  of  CTX-induced  catecholamine 
secretion  [63].  All  of  these  compounds  may  be  considered  as  new  candidates  for  CFP  
treatment [62–64].  
2.3. Organisms producing CTXs 
Gambierdiscus  toxicus  has  been  considered  the  main  species  responsible  for  the  production  of 
CTXs. This marine dinoflagellate usually grows in tropical and subtropical waters as an epiphyte on 
macroalgae  in  coral  reefs,  mangroove  systems,  and  on  artificial  surfaces  [65]  or  sand  [66].  Five 
additional  Gambierdiscus  species  were  later  described:  G.  belizeanus  [66],  G.  yasumotoi  [67],  G. 
polynesiensis, G. pacificus, and G. australes [68]. Production of toxins by some of these species has 
been  described  [67–70],  but  their  direct  implication  in  CFP  outbreaks  has  never  been  confirmed. 
However, cases attributed to G. toxicus could have been caused by other Gambierdiscus species. 
These  studies,  along  with  recent  works  [71,72],  underline  the  high  degree  of  complexity  in 
Gambierdiscus taxonomy. Due to uncertainties regarding the identification of Gambierdiscus species, 
strongly hampered studies on the ecology of this dinoflagellate, an extensive revision of the six already 
described  species  was  further  conducted  by  Litaker  et  al.  [73].  The  revision  was  based  upon 
morphological  and  phylogenic  analysis,  and  led  to  the  description  of  four  new  species,  i.e.,  G. 
caribaeus, G. carolinianus, G. carpenteri, and G. ruetzleri [73]. It was also proposed that the original 
species, G. toxicus, of Adachi and Fukuyo [28], may in fact include multiple species [72,73]. However, 
no toxicological data is currently available regarding these four new species.  
Ecological and physiological studies have been conducted on both wild and cultured Gambierdiscus 
spp. in order to elucidate the factors influencing the occurrence of toxic Gambierdiscus blooms. The 
existence of genetically determined species producing CTXs was first proposed by Holmes et al. [74], 
and is supported by recent data that identified three CTX super-producing clones of G. polynesiensis 
among 20 Gambierdiscus clones tested [69]. The role played by environmental conditions in favoring 
the  growth  of  toxic  clones  in  natura  should  also  be  considered  [75].  The  exact  nature  of  factors 
influencing  the  toxicity  and  abundance  of  Gambierdiscus  spp.  remains  unclear.  However,  light 
intensity, salinity, water temperature, nutrients, growth stage, and the presence of bacteria have been 
shown to influence the growth and toxicity of Gambierdiscus spp. [76–79].  Mar. Drugs 2010, 8 
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Other  toxin-producing  dinoflagellates  coexist  with  Gambierdiscus  spp.  in  ciguatera  endemic 
regions, such as species of the genera Prorocentrum, Ostreopsis, Coolia, and Amphidinium. Their 
involvement in CFP is debatable; these species do not produce CTXs, but do produce other toxins. The 
cyanobacteria of the genus Hydrocoleum Kü tzing was recently proposed as a new additional source of 
CFP based upon the occurrence of unclassical CFP outbreaks after the consumption of giant clams and 
molluscivorous fish [80]. However, these poisoning events were recently suggested to be linked with 
the accumulation of the neurotoxin homoanatoxin-a [81,82]. 
Many bioactive compounds have been isolated from G. toxicus, i.e., maitotoxins (MTXs) [27,83], 
gambierols  [84],  and  gambieric  acid  [85,86].  MTX  increases  intracellular  calcium  [87]  and  is 
considered one of the most potent among marine biotoxins when injected intra-peritoneally (i.p.) in 
mice, with an LD50 (i.p. 24 h.) of 50 ng.kg
-1 [88]. However, MTX has no proven role in human 
intoxication  due  to  its  low  capacity  for  accumulation  in  fish  flesh  and  low  oral  potency  [88]. 
Gambierol was described as a potent potassium voltage-gated channel blocker [89] and was suspected 
to participate in the symptoms of CFP [90,91]. Gambieric acids were isolated from the culture medium 
of G. toxicus and were described as potent antifungal polyether compounds [86].  
2.4. Chemical structure of CTXs and geographical variability 
Ciguatoxins are lipophilic polyethers isolated from fish and Gambierdiscus spp. cell extracts (wild 
samples and cultures). Ciguatoxins are odorless, colorless, devoid of heteroatoms other than oxygen, 
and  bear  few  conjugated  bonds.  Structurally  distinct  CTXs  from  the  Pacific  (P-CTX),  Caribbean  
(C-CTX), and Indian Ocean (I-CTX) have been reported [92–100].  
CTX-1B, a 60 carbon polycyclic ether, was the first CTX completely described in 1990 by Murata 
et  al. [100].  Numerous  congeners  of  CTXs,  originating  from  fish  and  microalgae  of  the  Pacific  
(P-CTXs),  were  further  described.  These  congeners  presented  slight  modifications  of  their 
lipophilicity.  Occurrence  of  these  different  toxins  in  fish  and  microalgal  samples  vary.  However,  
P-CTX-1 (P-CTX-1B) usually dominates toxin profiles in the carnivorous fish tissue of the Pacific 
[45,92].  In  order  to  classify  the  different  congeners  of  CTXs,  Legrand  et  al.  [101]  proposed  the 
distinction between two families of P-CTXs (types 1 and 2) according to the number of carbons and 
the structure of the E ring (See Table 1 and Figure 1). Two CTXs from the Carribean Sea (C-CTXs) 
were first isolated by Vernoux and Lewis [94], and further identified structurally in 1998 [94,102] 
(Table 1 and Figure 1). Additional congeners were later identified by Pottier et al. [97,98]. More 
recently,  four  Indian  Ocean  CTXs  (I-CTXs)  were  isolated  [96],  but  their  structural  determination 
remains to be established. 
2.5. Toxicity and mechanisms of action  
CTXs are extremely potent marine toxins with an LD50 in mice (i.p.) equivalent to 0.25, 2.3, and 
0.9 μg kg
-1 for P-CTX-1, P-CTX-2, and P-CTX-3, respectively, leading to the observation that the 
degree  of  oxidation  is  positively  correlated  with  potency  [45].  Recently,  the  54-deoxyCTX  was 
described as more potent than P-CTX-1 [22]. P-CTXs are more potent than the C-CTXs (LD50 of 3.6 
and 1 μg kg
-1 for C-CTX-1 and C-CTX-2) and I-CTXs (approximately 5 μg kg
-1). No more than an Mar. Drugs 2010, 8 
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estimated 1 ng P-CTX-1 per kilogram of body weight is needed to elicit the occurrence of mild CFP 
symptoms in humans [19].  
Table 1. Diversity of CTXs isolated from fish and microalgal origin [92,94–100]. 
Origin 
Number 
of rings 
Number 
of carbons 
Examples of CTX 
Molecular 
Weigh 
Source 
Pacific (P-) 
Type 
I 
13  60 
CTX (CTX1B, CTX-1)  1110.6  carnivorous fish 
CTX2A2 (CTX-2, 52-epi-54-deoxyCTX)  1094.5  carnivorous fish 
CTX2B2 (CTX-3, 54-deoxyCTX)  1094.5  carnivorous fish 
CTX4A  1060.8  G. toxicus, G. polynesiensis 
CTX4B (GTX-4B, Gt 4b)  1060.8  G. toxicus, G. polynesiensis, 
herbivorous fish 
Type 
II 
13  57 
CTX3C  1022.8  G. toxicus, G. polynesiensis, 
herbivorous fish 
CTX2A1  
(2,3-dihydroxyCTX3C) 
1056.0  carnivorous fish 
Caribbean (C-)  14  62 
CTX-1  1140.7  carnivorous fish 
CTX-2  1140.7  carnivorous fish 
Indian (I-)  nd  nd 
CTX-1  11406  carnivorous fish 
CTX-2  1140.6  carnivorous fish 
CTX-3  1157.6  carnivorous fish 
CTX-4  1157.6  carnivorous fish 
Figure 1. (a) General and specific structures of Pacific ciguatoxins (P-CTXs) (b) Structure 
of Caribbean ciguatoxins (C-CTX-1). 
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Figure 1. Cont.  
Type 2 P-CTXs (Ex.: CTX3C, CTX2A1): 
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E
M
N
56
A
O
O
O
O
H
H
H H
H
H
O
O
H
O O H
H
H
H
OH
H
H
H
H H
H
H
O
O
HO
H H
OH
OH
H
H
HO
O
O
O
O
1
 
CTXs directly target the voltage-sensitive Na
+ channels, thus inducing many effects at the cellular 
and physiological levels, such as membrane excitability, release of neurotransmitter [103], axonal and 
Schwann oedema [104,105], increase of intracellular calcium [106], and blockage of voltage potassium 
channels [107]. CTXs stimulate Na
+ entry [108] through specific binding to site 5 of the voltage-gated 
Na
+ channel [109]. The affinity of the different congeners of CTXs for the voltage-dependent Na
+ 
channel is proportional to the congeners’ respective intraperitoneal LD50’s in mice [110].  
Extensive reviews on the mechanism of action of CFP exist [111]. We want to consider a recent 
hypothesis that explains possible chronic effects of CFP. The chronic long lasting effects of CFP 
actually seem to differentiate CFP from other marine toxin intoxications. Neurological symptoms are 
consistent  with  CTXs’  interactions  with  voltage-gated  Na
+  channels.  However,  all  the  symptoms 
produced during CFP may not be exclusively due to the blockage of the voltage-gated Na
+ channels 
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[112]. The chronic fatigue syndrome that may last for weeks or months [113] has been related to high 
nitric oxide (NO) production [114]. Penil and muscular relaxation, as well as  L-type Ca
2+ channel 
activation, were shown to be NO-mediated via the NOS pathway [115,116]. Up-regulation by CTXs of 
NO and inducible nitric oxide synthetase (iNOS) was recently confirmed by Kumar-Roiné  [112]. As a 
matter of fact, P-CTX-1 was shown to induce a time- and dose-dependent increase in NO release 
within  macrophage  RAW  264.7  cells,  through  a  high  and  prolonged  increase  in  iNOS  mRNA 
expression.  It  was  further  proposed  that  prolonged  voltage-gated  Na
+  channel  activity  stimulates  
N-methyl-D-aspartate  (NMDA  receptor),  resulting  in  Ca
2+  influx,  followed  by  constitutive  NOS 
activation, thus leading to NO production. NO would in turn interact with the oxidative stress chain, 
resulting in iNOS gene stimulation, leading to further NO production. NMDA activation by CTXs is 
still not demonstrated, but brevetoxin-induced, prolongated voltage-gated Na
+ channel activity has 
been  shown  to  induce  activation  of  the  Ca
2+-independent  iNOS  activity.  The  NOS  pathway  may 
provide insight into new therapies for CFP, such as NO scavenging or iNOS inhibition, although 
mannitol,  as  well  as  some  traditional  remedies,  has  been  described  as  free  radical  
scavengers [117,118]. 
3. Methodologies for CTXs Determination 
3.1. Importance of CTX determination 
CFP is the result of simultaneous exposure to a suite of closely-related but structurally distinct 
congeners (CTXs) with different intrinsic potencies and very low concentrations in fish. Indeed, it is 
well known that toxin profiles differ largely between herbivorous and carnivorous fish, and both at the 
species and individual levels.  
For a number of marine toxins, data from human intoxication incidents and also toxicological data 
obtained in laboratory tests, (including biological (in vivo or in vitro) and physico-chemical assays 
using purified standards) have contributed to help regulatory authorities set a Maximum Permitted 
Level (MPL) for each of these toxins. Above this MPL, seafood must be banned from the market. For 
instance, based upon the evaluation of CTX content in fish samples using a mouse bioassay, an MPL 
of 0.01 ng g
-1 P-CTX-1 equivalent toxicity was proposed for fishery products caught in the Pacific in 
2000 [18,19]. This MPL was derived from estimation of CTX content in fish samples taken from meal 
remains after a mild outbreak of CFP. The value takes into account a 10x safety factor in order to 
address individual human risk and possible uncertainties in the assay accuracy [18,19] and in the 
assumptions of the amount of fish consumed. For Carribean fish, an MPL of 0.1 ng g
-1 C-CTX-1 has 
been proposed [94]. In 2008, Dickey [119] presented an analysis of more than 100 outbreaks of CFP in 
the U.S. for the period of 1998–2008 in which exposure levels to CTXs were consistent with the MPL 
previously proposed for Pacific and Caribbean region fish [119,120]. These MPLs - established from 
analysis  of  fish  tissue  implicated  in  CFP  -  are  currently  used  as  acceptable  levels  to  guarantee 
consumer protection [120]. 
One important issue regarding CFP management in a specific area consists of the discrimination of 
non-toxic from toxic fish specimens. Presently, this requires cost and the time-consuming procedures 
of  extraction,  purification,  and  determination  of  CTXs  from  the  flesh  of  fish.  Optimization  of Mar. Drugs 2010, 8 
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extraction and purification protocols to improve recovery of CTXs is still required. The development 
of methodologies that could detect CTXs with high specificity and sensitivity, and which are suitable 
for routine monitoring of food, is a matter of concern. Additionally, the confirmation of the presence of 
CTXs  in  food  or  in  the  blood  of  patients  may  help  the  clinical  diagnosis  of  CFP  [4],  enabling 
differential  diagnoses  from  other  forms  of  ichtyosarchotoxism.  Furthermore,  purification  of  CTXs 
from the flesh of fish is of real interest for the identification of new CTX congeners  and for the 
characterization of CTX profiles in different regions [24]. Finally, recovery of CTXs for reference 
production  from  fish  material  or  for  pharmacological  studies  in  the  elucidation  of  the  CTXs’ 
mechanisms of action also requires the development of reliable methods of detection.  
The  abundance  and  distribution  of  Gambierdiscus  spp.,  as  well  as  CTX  production  by  these 
microalgae in natural populations, are routinely monitored by some laboratories in ciguatera endemic 
areas. The occurrence of toxic (CTX producing) Gambierdiscus spp. blooms may be used as a bio-
indicator of local ciguatera risk in a specific area [33,34]. Some time (months) after the occurrence of 
toxic  Gambierdiscus  spp.  blooms,  the  appearance  of  CTX-containing  herbivorous  fish  may  occur 
[121]. Determination of CTXs in phytoplankton samples containing Gambierdiscus spp. may also have 
importance for geographical ciguatera risk assessment [70,122]. Determination of CTX production by 
Gambierdiscus spp. cultures, in parallel with taxonomic studies of the genus Gambierdiscus, is crucial 
for  associating  toxin  production  with  a  particular  Gambierdiscus  species  [67,68].  Studying  toxin 
production in cultures also helps to describe the kinetics of CTX production under specific, controlled 
laboratory conditions [77,122,123] or according to the physiological growth stage of Gambierdiscus 
spp. cells [69]. Production of gambiertoxins (ciguatoxin precursors e.g., CTX-4B) by in vitro culturing 
of  Gambierdiscus  spp.  was  proposed  as  an  alternative  supply  of  CTXs  for  reference  material 
production [16].  
In  this  chapter,  the  different  strategies  proposed  for  CTX  quantification  are  considered.  This 
includes  describing  sample  preparation  (for  fish  and  microalgae)  and  the  different  existing 
methodologies  for  CTX  quantification.  Interestingly,  and  contrary  to  other  microalgal  toxins 
implicated in food poisoning, no recognized official method for the determination of CFP toxins exists.  
3.2. Sample preparation for CTXs determination 
An important issue when considering method development for marine toxins is sample preparation 
prior to toxin determination. Numerous protocols for sample preparation for research or monitoring 
purposes, or both, have been reported in the scientific literature for CTXs during the last decade. The 
nature of the sample, either of fish or microalgae, will have to be specifically addressed, with regard to 
the elimination of interferences and the expected toxin profiles. These two factors differ significantly 
between fish and microalgae. Methods for CTX determination that follow sample preparation may also 
determine the grade of purity of extracts required for the analysis. For example, purification of extracts 
through  various  Solid  Phase  Extraction  (SPE)  steps  after  solvent  partition  is  often  applied  when 
analyzing CTX content using LC-MS/MS and CBA methods [119]. Another matter of concern is the 
time required, especially for routine monitoring purposes, for sample preparation to guarantee good 
CTX  recovery.  A  rapid  extraction  protocol  using  LC-MS/MS  analysis  [124]  has  recently  been 
developed  to  improve  the  usefulness  of  the  screening  of  CTX-containing  fish.  This  protocol  is  Mar. Drugs 2010, 8 
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two–to-three times faster than the ―long‖ procedures [125]. During another survey of ciguatera [33], an 
additional rapid sample preparation protocol was described for the screening of CTX-containing fish 
using the Receptor Binding Assay (RBA). We present here a selection of protocols published for the 
preparation  of  microalgal  and  fish  samples  containing  CTXs.  These  methods  are  detailed  below 
according to the detection method implemented following sample preparation. 
3.2.1. Fish samples 
Fish sample preparation for CTX determination usually follows a general pattern derived from the 
first descriptions given by Scheuer’s [126] and Yasumoto’s teams [127] in the 1960s. Acetone or 
methanol  based  extraction  is  used  for  the  recovery  of  lipophilic  compounds  from  fish  samples. 
Acetone extraction, being more efficient, is preferentially used, and is often implemented two or three 
consecutive times to optimize toxin recovery. A second step consists of the elimination of excessive 
fatty acids based upon solvent partition with hexane, diethyl ether, or chloroform (as in accordance 
with the protocol). Additional purification procedures using SPE have been proposed to improve the 
elimination of resulting fatty acids. Because fatty acids may vary in quantity and quality with the fish 
species,  origin,  or  age  of  the  fish,  and  because  different  CTXs  may  be  present  according  to  the 
geographical origin of samples, certain conditions of the purification steps, such as volume and solvent 
gradient, have to be modulated.  
The standard mouse bioassay (MBA) performed by intraperitoneal (i.p.) injection of the diethyl 
ether fraction obtained after liquid partition  of fish extracts is often used for the surveillance and 
determination of CTX-contaminated fish [128–130]. Improvement of sample preparation to enhance 
detection and accurate determination of CTXs in the flesh of fish using the MBA was investigated by 
adding a clean-up step with Florisil SPE to increase the purity of the ether fractions [131] (Figure 2). 
According to these authors, this additional purification step enhanced recovery of P-CTX-1 to 76% vs. 
63% with the standard purification protocol.  
Dickey et al. [119] proposed another purification protocol for CTXs to be used with CBA and  
LC-MS/MS analysis (Figure 3). This protocol is based upon the use of successive solvent partitions, 
followed  by  various  SPE  clean-up  procedures.  The  method  was  reported  to  be  successful  for  the 
clinical recognition and epidemiology of Pacific and Caribbean ciguatera [119].  
Availability of flesh may be one limitation for the determination of CTXs in leftovers meals. In 
2007, Darius et al. [33] described a rapid extraction procedure implemented for routine monitoring of 
ciguatera risk in French Polynesia that is suitable for RBA analysis. This procedure, based upon the 
extraction of 5 g of fish flesh, is applicable to both herbivorous and carnivorous fish of the Pacific 
(Figure  4)  [33,34].  Extraction  efficiency  presented  good  concordance  with  standard  extraction 
protocols for highly contaminated samples [132].  
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Figure 2. Solid-phase extraction clean-up of CTXs containing fish extract for use with the 
mouse bioassay according to standard preparation procedure ([128] and [131]). 
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Figure 3. Extraction and purification of CTXs from fish samples (caught in the Pacific and 
Caribbean) for use with Cell Based Assay and LC-MS analysis [119]. 
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Figure 4. Extraction and rapid purification of CTXs from Pacific fish samples to be used 
with the Receptor Binding Assay [33]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A CTX rapid extraction method (CREM) was developed by Lewis et al. [124] in order to reduce the 
time of sample preparation with the extraction of only 2 g fish flesh to be used with LC-MS analysis 
(Figure 5). The CREM was described as a successful procedure for P-CTX determination in Pacific 
carnivorous fish, allowing 95% recovery of spiked P-CTX-1 and 85% recovery of P-CTX-1 spiked at a 
concentration close to the limit of quantification of the method (0.1 ppb). According to these authors, 
CREM  combined  with  LC-MS  improves  sensitivity  and  allows  multiple  analyses  per  day  [124]. 
Stewart  et  al.  [125]  further  adapted  the  CREM  described  by  Lewis  [124]  with  an  additional 
methanol:hexane extraction step while omitting the final normal-phase SPE clean-up. This modified 
CREM not only reduced the time of preparation for fish extracts while requiring only a small quantity 
of fish flesh, but also showed an excellent reproducibility for P-CTX recovery from fish flesh, as well 
as a lower detection limit of 0.03 ng g
-1 using LC-MS-MS [125].  
3.2.2. Microalgal samples 
Sample  preparation  procedures  for  CTX  determination  in  microalgae  are  still  based  upon  the 
original extraction protocols previously described for CTX (or gambiertoxin) characterization from 
wild and cultured G. toxicus [92,100,133,134]. The first step consists of extracting cell pellets using 
methanol (aqueous or absolute) [33,68–70,84,122,134] or acetone [100]. According to the aim of the 
research and the grade of purity required, the resulting crude extracts may be further purified for the 
separation  of  CTXs  from  other  concomitant  toxins  using  liquid/liquid  solvent  partition  with 
dichloromethane,  hexane,  or  diethyl  ether  [33,68–70,133–135],  separation  through  filtration  of 
Receptor 
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LC-MS/MS 
analysis 
insoluble MTX in -20 º C acetone [129], chromatography on SPE cartridges [33,69,70,100,133–135], 
or by high performance liquid chromatography (HPLC) [69,92,100,134].  
One important aspect to consider while dealing with Gambierdiscus spp. extracts is the possible 
interference caused by MTX, another major toxic compound produced by Gambierdiscus spp. isolates, 
as underlined in previous studies [68,69,77,83]. It has been shown that MTX-derived toxicity may vary 
according to strain origin or culture conditions [69,83,123] and that considerable quantities of MTX (in 
toxicity equivalents) may occasionally take over the production of CTXs [83]. 
Figure 5. Rapid extraction and purification procedures for CTX determination in Pacific 
fish samples using LC-MS/MS analysis (CREM-LC-MS/MS) [124]. 
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LC-MS/MS 
analysis 
Figure  6.  Extraction  and  purification  procedure  of  CTXs  from  wild  and  cultured 
Gambierdiscus spp. cell pellets [33,68,69]. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is clear that the purification procedure for CTXs is highly conditioned by the presence of MTX, 
and may vary according to the type of sample. For instance, highly concentrated MTX samples may 
require the combination of solvent partition with chromatographic fractioning using SPE or HPLC so 
as  to  improve  the  separation  of  CTXs  from  MTX.  Historically,  MBA  has  been  widely  used  for 
assessing the good separation of CTXs versus MTXs [69,83], although the presence of CTXs in the 
different  fractions  obtained  may  also  be  monitored  using  RBA  [33]  or  CBA  [136].  A  recently 
developed CBA for the detection of MTX may help with the identification of the interferences MTX 
produce during CTX purification steps [137]. Figure 6 illustrates a protocol for CTX extraction and 
Receptor 
Binding Assay 
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purification for use with the MBA and RBA [33,68,69]. In the case of further characterization of CTXs 
with LC-MS analysis, additional purification steps through SPE and HPLC fractioning are required 
[69]. This extraction procedure has been successfully used for the identification of toxic blooms of 
Gambierdiscus in field-monitoring programs [33], as well as for the assessment of the toxin profiles of 
highly potent G. polynesiensis strains [69].  
3.3. Methods for CTXs determination  
―Home-made‖ or traditional tests for discriminating safe fish from toxic ones should be briefly 
mentioned. These tests are widely used by local populations in ciguatera endemic areas, and include 
animal testing (e.g., feeding a piece of fish to a dog or a cat, observing avoidance of toxic fish by flies 
or ants, looking for the presence of a blood line at the tail of the fish [34], observing silver coins 
turning black on a hypothetical, cooked toxic fish, or feeling a sensation of tingling when rubbing the 
liver on the gums [34,138]). However, as stated by Banner et al. [138], these tests have very low credit 
and further discussion does not fit within the scope of this publication.  
The high diversity and structural complexity of CTX congeners present at trace levels in different 
matrices  (i.e.,  microalgae,  herbivorous  and  carnivorous  fish  tissue)  have  greatly  hampered  the 
development of reliable methods for their determination. In the course of developing CTX detection 
methods, one should consider the degree of specificity and sensitivity suitable for routine monitoring 
of CFP. An ideal universal method for CTX determination has yet to be developed, even though many 
methods, with varying success according to the application context, have been described. 
Before addressing the descriptions of the different methods of CTX determination, it is important to 
remark that problems regarding the availability of CTX standards constitute an important limitation 
upon method development. Only a few laboratories produce purified CTXs [119] and commercial 
CTX  standards  do  not  exist.  The  limited  availability  of  CTX  standards  and  ciguateric  reference 
material constitute major restrictions for the development, calibration, and validation of methods for 
CTX determination. These scarcities undermine the realization of pharmacological and toxicological 
studies  that  aim  to  elucidate  the  CTXs’  mechanisms  of  action  and  also  limit  the  production  of 
antibodies against CTXs.  
CTX analogs can alternatively be obtained via the production of gambiertoxins (CTX precursors) 
by cultures of Gambierdiscus spp. [16]. However, the ability to produce CTX precursors seems to be 
genetically determined in Gambierdiscus, and limited to only certain strains of Gambierdiscus spp. 
[69,74]. For example, the mass culturing of a ―super-producing‖ clone of G. polynesiensis allowed the 
purification of approximately 3.5 mg of pure algal CTXs from 2 ×  10
9 cultured cells [69], suggesting 
the need to increase efforts directed at the isolation of CTX ―super-producing‖ clones for reference 
material production.  
The synthesis of CTX  to resolve the lack of availability of CTXs  pure material appears as  an 
ambitious challenge reflected by its large (3 nm long) and complex ladder-like structure [139]. In 
2001, the total synthesis of CTX3C was achieved by Hirama et al. [139], based on highly convergent 
and efficient strategy for the assembly of structural fragments. This strategy was further improved by 
Inoue  et  al. [140,141]  for  a  higher  yield  recovery.  The  51-hydroxyCTX  and  CTX  
(CTX-1B) were also synthesized [142–144]. The total synthesis of gambierol, another toxin produced Mar. Drugs 2010, 8 
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by Gambierdiscus spp. that is suspected to have a role in CFP [90,91], was also described [145]. 
Efforts directed at the synthesis of CTX congeners are necessary and may accelerate the preparation of 
anti-CTX antibodies.  
Clearly, when selecting CTX determination methods, one should consider the frame of application, 
e.g., for food safety assessment, research, or diagnostic purposes. The development of simple and  
cost-effective individual tests (e.g., kits to be used by fishermen and consumers to check the safety of 
fishing products for commercialization or consumption, respectively), requires a different approach 
than  what  is  needed  by  the  CTX  recognition  methods  used  in  research  laboratories  that  look  for 
accurate  quantifications  (e.g.,  for  the  diagnoses  of  cases  of  CFP).  One  can  differentiate  between 
methods that provide results on toxicity (e.g., a cytotoxicity response) from methods that provide the 
quantification of a specific compound (e.g., LC-MS/MS). 
Comparative  studies  among  the  different  existing  methodologies  have  often  presented  good 
correlations.  For  instance,  RBA  values  for  CTX  toxicity  determination  correlated  well  with  those 
obtained  using  an  analytical  approach,  MBA  or  CBA [4,146–148].  A  comparative  study  between 
enzyme-linked  immunoassay  (ELISA)  and  CBA  also  indicated  a  high  correlation  between  both 
methods [149,150]. The same remark applies to CTX determination using CBA in parallel with LC-
MS/MS analysis [119,151]. All these methods show good results for the determination of CTXs at 
levels that can cause CFP in humans. 
Some of the present strategies implemented for the screening and confirmation of CTX-containing 
fish may result from the combination of various complementary approaches. Dickey [119] and Dickey 
et al. [24,120] reported CBA to be a useful toxicological tool for the screening of toxic fish samples, to 
be  then  confirmed  and  the  presence  of  CTXs  quantified  using  LC-MS/MS  analysis.  The  same 
approach was recently used during a survey of ciguatera along the Cameroon coastline [151].  
The current methods for CTX determination are presented below. They include MBA, bioassays on 
animal tissue, in vitro neuroblastoma CBA (Neuro-2a CBA), pharmacological RBA, immunological 
assays, and physico-chemical analytical methods. 
3.3.1. Bioassays with animals: The MBA for CTXs  
Attempts to use a wide variety of animals for the screening of ciguatoxicity in fish have been 
proposed  but,  excluding  mice,  bioassays  using  animals  have  met  limited  success  [152].  In  vivo 
bioassays consist of feeding or exposing animals to fish samples or direct injection of fish extract. 
Among these assays, mammalian based methods using mangoose [153] or cat [154] may produce 
symptoms resembling those of humans exposed to CTX-containing food. However, presently these 
methods are no longer used, as we have quite a good comprehension of CTXs’ mechanisms of toxicity. 
The implementation of such methods may be understandable in early toxicological studies or if new 
issues in toxicology need to be addressed. The MBA for CTX, further described, was first introduced 
by Banner et al. [153] and it is still the most widely used mammalian in vivo model for toxicity 
screening of CTXs. The chicken was also proposed as another model for a bioassay, showing higher 
sensitivity to CTXs than  MBA [155] with easier handling. However, probably due to the lack of 
standardization, or the fact that a non-mammalian model may be not considered a good toxicological 
model, this model is not presently used, to the best of our knowledge. Invertebrate-based assays like Mar. Drugs 2010, 8 
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the brine shrimp assay [151,156], mosquito assay [154], and diptera larvae assay [157] are low cost, 
simple detection methods that require low quantities of samples and can be used to screen numerous 
samples in a short time period. These assays are not widely used in laboratories responsible for the 
screening of ciguatera, probably because they lack specificity or because they may not be suitable for 
CTX quantification [24,158].  
The mouse model is widely used in many diagnostic and research fields, such as drug development, 
cosmetic toxicological studies, and drugs, additives, or food contaminant testing [159]. MBA is still 
the  current  official  detection  method  for  most  marine  toxins,  such  as  the  paralytic  and  diarrheic 
shellfish poisoning toxins, which has been used for the protection of consumers for the past decades 
[159]. However, ethical pressure to avoid research with animals is supporting the development and 
validation of alternative or complementary methods (Directive 86/609/EEC) [160] for the elimination 
or decreased use of MBA’s in routine food safety assessments. With respect to ciguatera, MBA’s have 
been widely used for the screening of ciguatoxicity in fish samples. The MBA was first introduced by 
Banner et al. [153] and further revised by Yasumoto et al. [161] before its validation by Lewis and 
Sellin [162] as a reliable method for the selective determination of CTXs. The method proposed by 
Lewis [129,130] allows the quantification of natural levels of CTXs in the fish flesh to up to 20 mg of 
ether extract. The relationship between the dose and time to death is used to quantify toxicity of the 
extract. Usually the mouse unit (MU) is used and it is defined as the lethal dose (LD) of a toxin that 
kills a 20 g mouse in 24 h after i.p. injection. One MU is equivalent to 5 ng, 18 ng and 48 ng for 
Pacific CTXs, P-CTX-1, P-CTX-2 and P-CTX-3, respectively [45,162] and 72 ng for pure Caribbean 
CTX-1  [147].  Dose  and  time  to  death  relationship  for  a  mix  of  ciguatoxins  typically  found  in 
carnivorous fish is defined according to the equation: log MU = 2.3log(1 + 1/T), where T is the time to 
death in hours [46]. It was formerly suggested that any fish containing above 2.5 MU/100g should be 
avoided  as  food  [161]  since  ciguatoxins  are  potent  neurotoxins  that  may  have  long-term  
neurological effects.  
Protocols for the MBA are well described in Lewis [129,130]. Generally, mice of 20 ±  2 g of either 
sex are marked for easier identification and each extract tested is assayed in duplicate. An aliquot of 
the extract is evaporated until dry, weighed, and re-suspended in a physiological solution (0.8–0.9% 
NaCl, 1–5% Tween 60) at a final volume of 0.5 mL for each mouse to be injected. Injection of extracts 
occurs  in  the  ventral  peritoneum of  mice  (i.p injection)  using  a  fine short  needle syringe. Mouse 
handling during injection is detailed in Lewis [129]. At this stage, the suggested amount of fish extract 
injected per mouse may vary according to the author. Dickey et al. [163] recommend an injection 
volume of 0.5 mL of physiological solution containing fish extract with a residue weight that should 
not exceed 20 mg. The dose of extract injected per mouse could, for example, correspond to muscle 
tissue fresh weight equivalents of 45, 90 or 180 g. Control mice received Tween/Saline solution only. 
For each marked mouse, in addition to the weigh, sex, and quantity of extract injected, it is necessary 
to control the time of injection, signs of intoxication, rectal body temperature (optional), and time to 
death [129]. Mice should be observed intermittently for up to 48 h, and should be studied more closely 
during the first two hours after injection [129]. Sub-lethal doses of CTXs should be associated to a 
growth depression within four days of injection [130,131]. Signs of ciguatoxicity include: inactivity, 
piloerection, vasodilatation in ears, cyanosis of tail, feet, and muzzle, unsteady gait, tremor/convulsive 
jumping, and death. However, reliable characterization of CTXs requires observation of hypothermia Mar. Drugs 2010, 8 
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below 33 ºC , dyspnea with gasping, severe diarrhea, hypersalivation, and lacrimation [162]. If short 
survival  lengths  are  observed,  doses  should  be  reduced  to  observe  symptoms  typical  of  CTXs. 
Sensitivity of mice to CTXs may vary according to the strain and housing conditions: it is suggested to 
establish a specific dose time to death relationship using mice from the breeding colony and for each 
source of CTXs to be assayed [130]. However, the limited amounts of pure CTXs make it difficult to 
establish the dose time to death relationship. 
The MBA is probably the most reliable in vivo bioassay system; it has many references of its 
application in research, including those that support its ability to clinically recognize ciguatera, and to 
a lesser extent, to monitor market fish. Presently, this in vivo toxicological assay is still currently being 
used  for  screening  of  CTX  bioactivity  in  fish  and  microalgal  extracts  [69,128,131,147].  As  an 
example, the MBA was implemented for surveillance of CTX-contaminated fishes in the market and of 
import sources in Hong-Kong so as to identify the problematic fish species and the ciguatera affected 
areas of importation [128]. Objective parameters for the MBA were adopted for CTX determination, 
especially with respect to the detection of sub-lethal amounts of CTXs, with the measure of body 
weight depression at day 4 after injection. Sublethal doses were estimated to range between 0.18 and 
0.45 MU 20 mg
-1 ether extract [128]. According to Wong et al. [131] (Figure 2), a modification in the 
purification procedure with respect to standard protocols allowed for the elimination of unnecessary 
lipid matrix. This modified procedure was reported to induce a more rapid death of mice compared to 
mice injected with non purified diethyl-ether fractions (in accordance with the standard purification 
protocol) [131]. This result suggested that the matrix inteference suppresses or retards the toxic effect 
of CTXs through a possible interaction of matrix compounds with CTXs at their target sites [131]. 
Such a modification in the purification procedure for use with the MBA may improve the detection of 
CTXs from suspected cases and borderline case samples. In the case of microalgal extracts, the MBA 
with  a  dichloromethane  fraction  of  cultured  G.  polynesiensis  allowed  for  the  detection  of  CTX 
bioactivity at different growth stages of the culture, thus allowing for the detection of a peak toxicity 
value at the onset of the senescent phase. This peak value was estimated at 43 ×  10
-5 MU cell
-1 [69]. 
MBA  also  helped  for  the  purification  of  pure  algal  CTXs  directly  produced  by  G.  polynesiensis 
through  the  location  and  quantification  of  CTXs  bioactivity  in  each  fraction  resulting  from  the 
different purification steps [69].  
The  MBA  allows  a  reasonable  and  sensitive  detection  of  CTXs  [164]  whenever  signs  of 
intoxication of mice are consistent with CTXs [19], but its utility is limited by the requirement of a 
dose-response curve [130,164] with purified CTXs for accurate quantification (since the dose-response 
curve is not linear) [130]. Additionally, free unsaturated fatty acids (e.g., Docosahexaenoic acid, DHA) 
interfere with the  MBA. Despite  its extended application,  its  need  for the  maintenance of animal 
colonies,  its  cumbersome  execution,  and  its  ethical  concerns,  has  favored  its  replacement  with 
alternative or complementary methods that are more suitable for laboratories in charge of ciguatera 
management. As an example, the MBA has been used since 1990 by the FDA Gulf Coast Seafood 
Laboratory  for assessment of suspected toxic fish samples  to  support clinical diagnostics  until its 
replacement in 1994 by the in vitro bioassay (described below) [119]. The MBA is unsuitable as a 
market test for individual checking of CTXs; however, it remains a toxicological tool that is accessible 
to many laboratories and is capable of effective clinical recognition. This is particularly important for 
those who lack access to other validated alternative methods. Mar. Drugs 2010, 8 
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3.3.2. Bioassay with tissues 
The  contractile  activity  of  CTXs  was  investigated  on  atria  isolated  from  guinea  pigs  and  was 
described to induce a prolonged, positive ionotropic effect upon the electrically driven atria [165]. This 
effect was further refined to allow the detection of CTX containing fish extract based upon the guinea 
pig atrium assay. The assay consisted of measuring the ratio between the amplitude of contraction of 
the guinea pig atrium after the addition of extract with the initial amplitude of untreated atrium [166]. 
This assay proved useful when CTXs were present at high concentrations, and has been used for the 
confirmation of ionotropic activity in fish extract [150]. However, the assay is likely to be suitable 
only for research purposes; the availability of tissue produces a technical limitation. 
3.3.3. In vitro bioassays: CBA  
In vitro cell models provide important tools for studying the effect of toxins in cells isolated from 
different tissues and for comprehending the mechanisms of action in cells that present specific targets 
(e.g., receptors) for the toxin in question. In vitro approaches allow more comprehensive toxicological 
profiles, which are of additional value beyond the single ―hazard identification‖ [167]. Cells respond 
rapidly to toxic stress through the alteration of metabolic rates, cell growth, or the transcription of 
genes that control basic functions. Consequently, the CBA has been developed for the analysis of food 
designated for human consumption [167]. The development of cytotoxicity assays for toxin detection 
has important methodological implications and represents a clear advancement in hazard identification 
because the use of cultured cells is likely to replace the use of living animals [168]. Cytotoxicity can be 
defined as the potential of a compound to induce cell death [167]. Numerous endpoints have been 
developed to assess cytotoxic effects. The [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium] MTT 
test [169] is the most widely used endpoint for cytotoxicity screening of CTX-containing fish extracts 
[119,150,151]  and  of  microalgal  extracts  [70,136].  MTT  is  reduced  by  the  mitochondrias  of 
metabolically active cells into a blue formazan product that can be easily quantified using a standard 
spectrophotometer  [169].  Such  a  colorimetric  assay  requires  minimal  processing  and  allows  for 
accurate and reproducible quantification of toxic effects [170].  
The specificity of the CBA for one particular group of toxins is a challenge for its application in 
toxicological contexts [168].  Having a specific assay for a targeted family of toxins is crucial for 
diagnostic purposes because several toxic compounds can be present within natural samples, or the 
sample itself may cause cell death. The lack of specificity in cytotoxicity assays may hinder their 
application in screening marine toxins in natural samples. However, in another aspect, a cell-specific 
toxicity  has  been  recognized  based  upon  sensitivity  of  the  cell  model  or  impairment  of  specific 
functions [167]. Specificity of the CBA may also be achieved with modifications introduced regarding 
the action of toxic compounds that enhance or hinder the compounds’ cytotoxic effects. For example, 
specific agonists or antagonists of some toxins have been used as described for the detection of several 
neurotoxins, such as saxitoxin, brevetoxin, ciguatoxin, and palytoxin [148,171–175].  
As for the application of CBA to marine toxins, the Neuro-2a neuroblastoma cell model (Neuro-2a) 
was first proposed to evaluate numerous neurotoxins, such as brevetoxins, ciguatoxins, tetrodotoxins 
or saxitoxins, which target voltage-gated sodium channels (VGSC) [176]. Binding of neurotoxins to Mar. Drugs 2010, 8 
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their receptors on the VGSC modulates the conformation of these proteins, which cause an activation 
or blockage of the sodium influx [176]. However, the diversity of ion channel systems in different cell 
types may compensate for these changes such that the action of neurotoxins alone is not sufficient to 
cause cell death in many cell types. To address this issue, it was proposed that the addition of other 
toxic  compounds  active  in  sodium  influx  can  result  in  disregulations  of  the  intracellular  Na
+ 
concentration [177]. For example, ouabain (O) blocks sodium efflux through an inhibition of the ATP 
dependent Na
+/K
+ pump [178] and veratridine (V) increases Na
+ permeability through a blockage of 
the voltage-gated Na
+ channel in the open position [176]. The combined action of both O and V results 
in an increase of intracellular Na
+ concentration that may result in cell death, depending upon the 
concentration tested. The addition of VGSC toxins that activate sodium influx (e.g., ciguatoxins and 
brevetoxins)  increases  the  toxic  effects induced  by  O  and  V,  leading  to  higher  toxic  effects  with 
respect  to  the  control. The  effect  of  the  addition  of  VGSC  toxins  that  block  sodium  influx  (e.g., 
saxitoxins or tetrodotoxins) counteracts the toxic effects of O and V, resulting in less toxic effects with 
respect to the control. Comparison of the cell response after exposure to natural samples in presence or 
absence of O and V allows for the detection of neurotoxins and for their characterization in accordance 
with the type of cell response obtained (i.e., the increase or decrease in toxic effects elicited by the 
treatment with O and V). The use of sodium channel blocking toxins (O and V) led to the development 
of various CBAs for the detection of neurotoxins [171,172,175,179–181]. The O/V dependent Neuro-
2a CBAs, which are specific for neurotoxins with the MTT test as an endpoint for cytotoxic effect 
quantification [172], are probably the best established CBAs for the detection of neurotoxins in natural 
samples  [171,172,175,179,180,182–184]  and  are  actually  the  most  widely  used 
[119,136,148,150,151,173,174,184] (Figure 7). A Neuro-2a CBA ready-to-ship kit, consisting of a 
modification of the Neuro-2a CBA with shippable plates and reagents to be used by unspecialized 
laboratories, was developed for the determination of VGSC blocking toxins in 1999 [185]. But it 
proved to be unsuccessful, probably due to a lack of stability during shipment or unreliable laboratory 
conditions.  
Other cell lines, including primary cell cultures, have been used to identify CTX mechanisms of 
action or to confirm and quantify the presence of CTX. For example, one can study these cells with the 
patch-clamp method [186,187] or a confocal laser scanning microscope to identify structural changes 
[104]. Some cell strains, such as the human embryonic HEK cell line or the neuroblastoma x glioma 
hybrid NG108-15 cell line, have been used for studying CTX’s modes of action or for studying their 
suitability for CTX determination by using the same approach as the one used with Neuro-2a cells 
(O/V dependent CBA) [106,188–191]. However, the current tendency of laboratories working on CTX 
determination using the CBA is to focus upon the Neuro-2a cell line. This is mainly due to the easy 
handling of this cell line, its elevated sensitivity to CTXs, and the accuracy in routine screening of 
CTXs compounds [119,120,136,148,150,151,173,192–194] (See Figure 7). Although the use of other 
cell models is not to be discarded, the use of the Neuro-2a cell line as a reference model is likely to be 
used in inter-laboratory comparison exercises for validation purposes and standardization. Mar. Drugs 2010, 8 
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Figure  7.  Neuroblastoma  (Neuro-2a)  cells  exposed  for  24  hours  to  P-CTX-1  in  the 
presence or absence (■) of ouabain (0.1 mM) and veratridine (0.01 mM). The proportion of 
O and V produced an approximate 20% cell mortality. No toxic effects of P-CTX-1 were 
measured when Neuro-2a cells were not treated with O and V (■). P-CTX-1 is toxic to 
Neuro-2a cells in the presence of O and V (●) with 50% of cell mortality produced with a 
concentration of 3.3 pg CTX-1 (IC50 = 3.3 pg P-CTX-1 mL
-1) [195]. 
 
Recent studies have described in detail protocols for the O/V dependent Neuro-2a CBA for CTX 
determination following either the original description given by Manger et al. [172] or with some 
modifications [119,150,174]. Briefly, Neuro-2a cells are maintained in 10% Fetal Bovine Serum (FBS) 
RPMI  medium  at  37  ºC   in  a  5%  CO2  humid  atmosphere.  For  experiments,  cells  are  plated  in  
96-well microplate in 5% FBS RPMI medium at a density ranging from 20,000 [151] to 100,000 cells 
per well [119] according to the author. After a 24 h incubation, one half of the plate receives treatment 
with O and V at a 10:1 proportion; concentrations of O and V may vary according to the author 
[119,148]. It is recommended to treat cells first with O and then with V, since the low pH of the 
solution of V may inactivate O. The natural sample or CTX standard to be tested is usually first 
evaporated to dryness to completely remove the solvent, and then dissolved in 5% RPMI medium. The 
resulting solution is serially diluted in RPMI medium and an aliquot of each dilution is directly added 
into the well of both halves of the plate (with and without O and V treatment) in order to compare cell 
response in the presence and absence of O and V treatment. An equal volume in each well is reached 
using  phosphate  buffer  solution.  When  checking  for  the  presence  of  CTXs  in  fish  samples,  it  is 
important to establish the maximum concentration of tissue equivalent (TE) to expose, since excessive 
matrix may be toxic to the cells. The quantity of matrix that one can expose varies according to the 
sample preparation procedure. For example, Dickey [119] used 2 g TE mL
-1 and Dechraoui [148] 
recommends no more than 20 mg TE mL
-1. For a quantitative estimation of neurotoxins present in 
natural samples, calibration of the assay with CTX standard(s) is necessary and recommended for each 
day of the experiment, since cell sensitivity may vary according to the day of experiment. After a 20 to 
24 hour incubation of cells with CTX standard(s) or sample, cytotoxic effects are evaluated using the 
MTT test. Absorbance values are expressed in percentage of effect or viability with respect to controls 
(with and without O and V treatment). The quantitative estimation of equivalents of CTX in samples Mar. Drugs 2010, 8 
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may be obtained using the substitution of the concentration of standard material that induced 50% of 
effects for the concentration of sample that induced 50% of effects [119]. The quantification of CTX 
compounds within samples presenting non-specific toxicity (toxic effects observed in the absence of 
O/V treatment) is achieved through a subtraction of both equivalents of CTX at the 50% of effects with 
and  without  O/V  treatment  [77].  The  subtraction  of  unspecific  toxicity  for  CTX  quantification  in 
microalgal samples may be used when interferences due to the presence of MTXs are suspected. 
The  Neuro-2a  CBA  has  been  widely  used  for  discriminating  between  toxic  and  non-toxic  fish 
samples [119,148], mainly for clinical recognition and for determining the epidemiology of ciguatera. 
It has proven to be a robust, reproducible, and high throughput method for studying CFP cases [119]. 
Its high sensitivity has allowed for the detection of small quantities of CTX. This is important as the 
IC50 for Caribbean CTX-1 is as low as 0.29 pg mL
-1 [119]; additionally, the quantification in fish tissue 
can be as low as 0.039 ng CTX-1 g
-1 [148]. The application of the assay has also been extended to the 
detection of CTXs of algal origin [70,136]. A chromatographic fractioning of natural samples (fish and 
microalgae) through SPE or HPLC, combined with the O/V dependent Neuro-2a CBA, may evidence 
CTX activity consistent with its retention time [119,148], and help with the separation of concomitant 
toxins  [119,136]. The high screening  capacity of the  method almost  finds  application  in  the CFP 
monitoring program. As an example, 64 fish from the Cameroon coastline were screened using the 
O/V dependent Neuro-2a  CBA, allowing  for the detection of  three  toxic  fish. This  detection  was 
further confirmed for CTX via analytical analysis. This result showed for the first time the health 
hazards associated with ciguatera along the southeastern Atlantic coast of Cameroon. However, as in 
any toxicological test, this assay will not discriminate amongst different neurotoxins acting in the same 
manner. Thus, confirmation of the identity of the toxic compounds using analytical approaches (further 
described) is required, whenever possible. This assay is part of the two-tiered protocol proposed by 
Dickey  for  the  reliable  determination  of  CTX  in  the  routine  screening  of  CTX-like  activity  in 
Caribbean and Pacific fish samples associated to human intoxication. 
In  vitro  bioassays  have  been  proposed  as  an  alternative  or  complementary  approach  to  animal 
testing in regulatory toxicology most notably in the field of chemicals, where they now succcessfully 
replace acute toxicity tests, such as the in vitro phototoxicity test or skin corrosivity tests [196]. In this 
respect, the Neuro-2a CBA shows great potential as a likely candidate in the quest for a validated 
reference method of CTX assessment in fish samples. 
3.3.4. Immunoassays 
By virtue of their theoretical advantages—high specificity combined with the high-resolution signal 
amplification of the antigen-antibody (Ag-Ab) reaction—Ab-based assays have been considered as a 
very promising approach for designing a rapid, reliable, and cost-effective method for mass screening 
of fish prior to consumption. However, production of specific Abs to CTXs has been greatly hampered 
by  CTXs’  extreme  scarcity,  toxicity,  and  chemical  complexity  [99,100,102,134,197].  Historically, 
Hokama's group in Hawaii [198] was the first to report the production of sheep polyclonal Abs (PAbs) 
to a partially purified CTX (CTX-1B). Some years later, Hokama and his co-workers were able to 
obtain mouse monoclonal antibodies (MAbs) to okadaic acid (OA) and CTXs [199,200] that could be 
produced in a potentially limitless and homogeneous supply. PAbs were first used in a tentatively Mar. Drugs 2010, 8 
 
1862 
improved  radioimmunoassay  (RIA)  [166,201]  and  in  the  enzyme-immunoassay  (EIA)  [200,202] 
format  assays.  Subsequently,  MAb-based  assays  were  claimed  to  yield  higher  sensitivity  and 
specificity [199,200,203,204]. Later on, numerous trials have been undertaken to validate such tests 
with  field  or  clinically  implicated  fish  samples  [203–206],  but  these  results  have  raised  some 
controversy  [163].  The  CTX  detection  kit,  « CIGUATECT
TM» ,  which  had  been  commercially 
available, was evaluated against the MBA for CTX determination with inconclusive results [163]. 
Presently,  a  new  kit  for  CTX  determination,  the  ―Cigua-Check‖  is  commercialized,  although  no 
information on its validation procedure is available. 
Following these pioneering studies, in the more recent past, a great deal of work has been done in 
this field. This has been facilitated through the use of synthetic ring fragments of CTXs to overcome 
the scarcity of the natural toxins and via the advent of modern molecular biology techniques, which 
can provide a set of immunological reagents whose specificity and affinity can be improved.  
Up to now, in spite of many attempts, there is no fully validated immunoassay screening that is 
commercially  available  for  ciguateric  fish,  but  promising  results  have  been  obtained  by  Hirama’s 
group  in  Japan  [207–214].  As  a  general  rule,  in  the  course  of  producing  Abs  specific  to  Ags  in 
laboratory  animals,  several critical steps  must  be  carefully evaluated and  planned such  as:  (i) the 
preparation and analysis of the Ags; (ii) the selection of the animal species in order to raise either only 
PAbs (e.g., sheep or rabbit) or PAbs plus MAbs (e.g., Balb/c mice); (iii) the selection of the adjuvant 
(e.g., Freund’s adjuvant); (iv) the development of an immunization schedule (i.e., determine the dose, 
volume, route, number and site of injection, and intervals between injections); and (v) the monitoring 
of  the  Ab  response  (e.g.,  ELISA  format  assays).  In  this  review,  only  some  of  these  aspects  will  
be presented. 
From an immunological standpoint, CTXs are considered to be haptens, i.e., low molecular weight 
compounds, which contain one or more antigenic determinants (epitopes), but which are unable to 
trigger an immune response per se, unless covalently conjugated to a large molecule acting as an 
immunogenic carrier. In a way that is similar to the haptens, there is a large diversity in the physico-
chemical nature of the carriers, and useful ones include polymeric macromolecules, which can be 
natural (e.g., polysaccharides or proteins from bacteria or viruses) and semi-synthetic or synthetic 
materials (e.g., polyamino acids or resin beads) containing one or more functional groups to which a 
reactant moiety can be attached. For a comprehensive review on Ab production methods, the reader 
can refer to Harlow and Lane [215]. 
Although a large number of chemical or photochemical coupling procedures were already available 
at the time of the first immunochemical studies on CTXs, their adaptation or the design of new ones 
have  remained  crucial  for  many  years,  to  develop  simple,  reproducible,  and  low-cost  methods 
applicable to poorly available lipophilic haptens, such as CTXs. In fact, considering the numerous 
studies  of  Hokama  and  his  co-workers  [199,200,203–206],  it  must  be  remembered  that  the 
carbodiimide coupling procedure employed to obtain CTX-protein conjugates is not fully adequate in 
the  absence  of  a  carboxyl  group.  In  1989,  the  elucidation  of  the  structure  of  the  main  congener  
P-CTX-1B revealed that the only functional group available was a primary hydroxyl located on a 4-C 
side chain of ring A [216]. In this context, our initial immunochemical knowledge of CTXs mainly 
came from experiments performed with more available hydroxylated polyether compounds, such as 
PbTxs [217–221], monensin [222], or even cholesterol [223]. Such experiments required a three-step Mar. Drugs 2010, 8 
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procedure:  (i)  the  formation  of  a  hemisuccinate  derivative  of  these  hydroxylated  haptens;  (ii)  the 
activation of the newly formed carboxyl group; and (iii) the conjugation to the protein. 
As it has been consistently reported, a critical epitope density (i.e., hapten/carrier molar ratio) of the 
conjugate  is necessary to trigger a strong specific immune  response in immunized  animals  [215], 
therefore conjugates must be carefully analyzed by various methods. These methods first require the 
separation of the conjugate from the uncoupled haptens by basic techniques (e.g., extensive dialysis 
against  the  buffer,  filtration  through  Sephadex  G25,  and  salt  or  solvent  precipitation).  After  this, 
conjugates are characterized by conventional methods e.g., UV analysis, radioactive incorporation of 
labeled hapten, di- or trinitrophenylation, and gel electrophoresis, or more sophisticated procedures, 
such  as  gas  chromatography,  high  performance  capillary  electrophoresis,  matrix-assisted  laser 
desorption  ionization  time-of-flight  mass  spectrometry  (MALDI-TOFMS),  and  high-performance 
liquid  chromatography  (HPLC).  However,  most  of  these  techniques  are  time-consuming  or 
exceedingly complex. Therefore, a rapid, cheap, and simple technique based upon a modification of 
the Habeeb’s trinitrophenylation method [224] was designed for poorly available haptens, such as 
CTXs [225].  
In the process of immunization of laboratory animals with a hapten–carrier conjugate, haptens act 
essentially as epitopes for binding to B cell surface receptors (membrane-bound immunoglobulins); 
this is a necessary step for B cell activation. In addition, the carrier provides not only distinct B  
cell-specific epitopes, but also class II T cell receptor binding sites, which are required to trigger T cell 
helper function, which in turn induces the differentiation of B cells into Ab-producing cells.  
Finally, it should be stressed that only a small fraction of the Abs produced in response to such 
multiple antigenic stimulation and complex cellular interactions are capable of binding to free haptens. 
For this reason, to evaluate the quantitative and qualitative Ab response, a soluble conjugate of the 
hapten with a heterologous carrier protein must be used in different immunoassay formats. The general 
procedure  requires  a  succession  of  washing  steps  and  incubation  periods  with  immunochemical 
reagents. Firstly, using a direct sandwich ELISA procedure, Ab-containing fluids can be titrated using 
a 96-well ELISA plate coated with a fixed concentration of the hapten-heterologous conjugate. Bound 
Abs  are  revealed  by  the  successive  addition of  the  secondary  Ab  conjugated  to  an  enzyme  (e.g., 
horseradish peroxidase or HRP) and its substrate (e.g., o-phenylenediamine or OPD). Finally the signal 
is recorded on a microplate reader designed for colorimetric or fluorimetric assays, depending upon the 
physico-chemical  nature  of  the  product  generated  by  the  enzyme-catalyzed  reaction.  Secondly,  to 
confirm the binding of the Ab to the free hapten, competitive inhibition ELISA (CIEA) is performed: a 
fixed and limiting amount of Ab is pre-incubated with increasing concentrations of the free targeted 
hapten. Afterwards, the mixture is dispensed into 96-well ELISA microplates coated with the hapten-
heterologous carrier  conjugate. Bound Abs are also revealed as previously  described.  This  simple 
CIEA format enables the determination of parameters, such as the dissociation constant (KD) [226] and 
the  limit  of  detection  (LOD),  which  is  calculated  by  assuming  that  a  decrease  of  three  standard 
deviations from the mean signal without inhibitor is significant (n ≥ 12). 
Extensive analyses of toxin profiles supported by LC-MS have revealed that different fish species 
always contain a mixture of very low levels of CTX congeners. These congeners mainly differ by the 
number and position of substituents located on the terminal A and M rings, and by the size of the E 
ring [102,197,227] (See Figure 1). Mar. Drugs 2010, 8 
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Therefore, as a good alternative to the lack of pure CTX, conjugates of the JKLM ring fragment 
[228], a carboxylic derivative of the right-hand tetracyclic portion of CTX-1B, were prepared with 
bovine serum albumin (BSA) and ovalbumin (OVA) for immunization and the monitoring of antibody 
responses, respectively [229]. In this study, conjugates were prepared according to a bulk procedure 
(3–5  mg  of  hapten)  via  an  activated  ester  method  in  a  semi-organic  medium  or  according  to  a 
microscale technique (300 µ g of hapten) via the formation of a mixed anhydride in a reversed micellar 
medium. Both coupling methods yielded epitope densities that were within the same range: 20 and 12 
for  BSA  and  OVA  conjugates,  respectively.  Monitoring  of  mouse  PAb  response  proved  that  a  
long-term immunization schedule (injections spaced at four-week intervals) was more efficient than a 
short-term protocol (injections spaced two weeks apart). Indeed, when using a CIEA format assay, the 
long-term related PAbs exhibited high affinity (KD = 7 ×  10
-9 M), but narrow specificity, whereas the 
short-term  associated  PAbs  showed  less  affinity  (10-fold  factor),  but  greater  immunoreactivity  to 
JKLM-related  natural  compounds  (i.e.,  CTX  congeners).  No  cross  reactivity  to  PbTx-3,  OA, 
monensin, or other polyether compounds was detected. With the aim of increasing the sensitivity of 
this assay, a biotin-avidin amplification system was used, which decreased the LOD for JKLM to  
1.23 ×  10
-9 M. 
Following this first demonstration of the relevance of using synthetic ring fragments of CTX-1B 
instead of the natural congeners, Hirama’s group [207–214] pursued their synthetic work to prepare 
suitable immunogenic conjugates of carboxylic derivatives of various CTX ring fragments via the bulk 
activated ester method. Analysis of the conjugates was performed by MALDI-TOFMS and the epitope 
density of the conjugates was always found to be compatible with good PAb response and production 
of MAbs in Balb/c mice. By using two ABC-ring fragments of CTX-1B coupled to BSA [208], they 
developed  an  elegant  and  rapid  MAb  screening  system  based  upon  surface  plasmon  resonance 
spectroscopy. This study stressed the importance of the A-ring side chain of CTX-1B for triggering 
adequate the mouse immune response. However, this conjugate was found to be poorly immunogenic 
(KD = 6 ×  10
-7 M). A milestone on the way to the development of a valuable immunochemical assay 
for CTXs arose from a double synthesis-based approach, which allows the setup of a direct sandwich 
ELISA for CTX-3C [210]. Pentacyclic ring fragments of the left and right wing of this CTX congener 
(namely ABCDE and IJKLM, respectively) were coupled to the keyhole limpet hemocyanin (KLH) 
and  BSA.  Following  mouse  immunization  with  the  two  KLH  conjugates,  several  MAbs  were 
produced. Two were selected on the basis of their strong reactivity towards their corresponding ring 
fragment  and  also  to  CTX-3C,  and  also  because  of  the  absence  of  cross-reactivity  to  the  
non-corresponding ring fragment and to other structurally related marine biotoxins, including OA, 
PbTxs congeners and MTX. Therefore, a direct sandwich ELISA based upon a capture MAb 10C9  
(KD  =  2.8  ×   10
-9  M  for  ABCDE)  and  a  detector  MAb  3D11  (KD  =  1.22  ×   10
-7  M  for  IJKLM) 
conjugated to HRP was proposed with a LOD of 5 nM for CTX-3C. The authors concluded that this 
strategy  was  expected  to  be  generally  applicable  to  all  CTX  congeners.  This  assumption  was 
confirmed three years later by the generation of MAbs against the common right wing of CTX-1B and 
51-hydroxyCTX-3C by using a KLH conjugate of the synthetic HIJKLM ring fragment [213]. MAb 
8H4, which strongly binds to 51-hydroxyCTX-3C (KD = 7.5 ×  10
-8 M for the right wing fragment) was 
found to discriminate between compounds that did or did not contain the 51-OH group. Similarly, a 
direct sandwich ELISA was proposed based upon the capture MAb 10C9 (KD = 2.8 ×  10
-9 M, for the Mar. Drugs 2010, 8 
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shared  left  wing  fragment  of  CTX-3C  and  51-hydroxyCTX-3C)  and  a  new  detector  MAb  8H4  
(KD = 7.5 ×  10
-8 M for the right wing of 51-hydroxyCTX-3C) conjugated to HRP. A LOD of only 1 
nM for 51-hydroxyCTX-3C was obtained. Finally, more recently, Tsumuraya and his co-workers [212] 
again used MAb 10C9 (directed to the left wing of CTX-3C) and another MAb 3D11 as a detector  
(KD = 1.22 ×  10
-7 M for the right wing of CTX-3C), and obtained a LOD of 5 nM for CTX-3C. 
Another study of interest performed by Hirama’s group described the production of recombinant Ab 
fragments (rFabs) to the ABCD ring fragment [209]. Starting from the deduction that the epitope 
recognized by MAbs in the CTX molecule encompasses more than three rings, mouse MAbs raised to 
ABC-KLH conjugates were genetically modified using phage-displayed Abs technology. In a CIEA 
study, three carefully selected rFabs displayed KD values for free ABCD in the range of 2.4 ×  10
-5 M to 
5.0 ×  10
-5 M. Moreover, rFab 1C49, exhibiting the highest affinity for ABCD, was also found to react 
to CTX-3C, though to a lesser extent. These last experiments and other studies [211,214] confirmed 
the importance of using more than  four-ring fragments as synthetic haptens in designing valuable 
hapten-carrier conjugates for the production of high affinity and specific MAbs to CTX congeners. 
Finally,  it  is  worth  mentioning  the  continuing  efforts  of  Hokama’s  group  to  improve  their 
previously described format assays using an anti-CTX MAb [199,200,203,204]. Keeping in mind that 
their membrane-based assay successfully allowed crude polyether toxin binding following a methanol 
extraction from fish flesh, but was unable to detect pure CTX in methanol, they adapted their bamboo 
stick-based assay to allow better binding to both types of toxic fractions [230]. This assay enabled the 
detection of P-CTXs and C-CTXs in the very low range of 0.078–5.00 ng/mL (i.e., 7.8 ×  10
-11 to  
5 ×  10
-9 M, assuming an average MW of 1000 Da for CTX congeners) with no cross-reactivity to OA, 
palytoxin and domoic acid. In another attempt, Hokama and his co-workers developed a sandwich 
ELISA for detection of CTX [231] using a capture anti-ABCD CTX ring fragment raised in chicken 
and a mouse MAb directed against JKLM ring fragment conjugated to HRP. A CIEA format enabled a 
LOD of approximately 5 pg mL
-1 of equivalent CTX per mg of extract (corresponding to 5 ×  10
-12 M), 
which lies in the range of the neuroblatoma cell assay. Moreover, the CIEA yielded consistent results 
when compared to this assay using flesh extract of fish caught in natura or raised in aquaculture  
farm [149,150].  
The  simplicity  and  low-cost  of  immunoassay,  coupled  with  its  speed  and/or  high  through-put 
sample  processing,  make  it  an  effective  method  for  monitoring  the  toxicity  of  fish  prior  to 
consumption. Nevertheless, it should be remembered that its applicability should not only rely on the 
affinity and specificity of the Abs for their target molecules, but also on the availability of simple and 
rapid sample clean-up and concentration procedures.  
At a single laboratory level, a fully acceptable CTX immunoassay will be one that uses affinity-
purified PAbs or a set of MAbs at high dilution in an EIA format rather than an RIA one. In addition, 
the assay should demonstrate a LOD around 1 nM or better (much effort is still needed toward this 
goal). The assay will have to be validated using various matrices (e.g., herbivorous or carnivorous fish 
and  Gambierdiscus  spp.  extracts)  obtained  through  adequate  clean-up  procedures  enabling  near 
quantitative recovery. Moreover, the assay will need to be accurate and robust and ultimately portable 
i.e., adaptable to field testing. 
As a final requirement for definitive validation, the availability of sufficient amounts of specific 
Abs to CTXs will allow for inter-laboratory studies aiming to correlate immunoassay-generated data Mar. Drugs 2010, 8 
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with  conventional  physico-chemical  and  more  functional  assays  based  upon  biological  or 
pharmacological properties of the CTX family. In any case, the assay must not yield false-positive 
results (negatively impacting the fisheries industry) or false-negative results (the worst from the public 
health point of view). 
Methods must be actively pursued to standardize immunochemical reagents. For this purpose, long-
term or inexhaustible sources of such tools and the issues associated with their use need to be correctly 
addressed, in order to define a routine cost-effective mass screening of fishes prior to consumption. 
Towards this goal, in vitro bioreactor systems (which enable adequate growth of hybridoma-producing 
specific  MAbs)  or  genetically  modified  bacteria  and  plants  (which  can  express  Ab  fragments  of 
defined specificity and affinity) will be of great help. 
Finally, it is noteworthy that the combination of MAbs 10C9 and 3D11 (directed to the left and the 
right wing of CTX-3C, respectively) was effective at neutralizing CTX-3C both in vitro and in vivo, 
protecting mice from an otherwise lethal injection of this toxin [207]. 
3.3.5. Pharmacological assay: Receptor Binding Assay 
A  well  established  approach  for  the  determination  of  CTXs,  as  well  as  other  toxins  acting  on 
voltage gated sodium channel (VGSC), is the Receptor Binding Assay (RBA). RBAs are very sensitive 
and  introduce  a  high  degree  of  specificity.  These  have  been  developed  since  the  1980s  from  the 
isolation  of  VGSC  obtained  from  animal  tissues,  and  are  basically  implemented  by  competitive 
measures of radioactivity using tritiated saxitoxin (STX) or brevetoxin (PbTx) [183,232,233]. 
The VGSC contains multiple binding sites for several neurotoxins produced by diverse organisms 
such as marine dinoflagellates, brown algae, plants, scorpions, spiders, cone snails, sea anemones, 
corals, fishes and frogs [183,234,235]. The RBA is based upon the principle of the affinity of a given 
toxin  for  a  specific  binding  site.  The  RBA  measures  the  binding  competition  reaction  between  a 
radiolabeled toxin and a non-radiolabeled toxin that binds specifically to the common receptor of the 
ion channel.  
Regarding  marine  toxins,  VGSC  inhibiting  toxins  like  the  saxitoxins  (STXs)  and  tetrodotoxins 
(TTXs) target the VGSC binding site 1. RBA was applied to STX and TTX detection using tritiated 
STX  as  a  binding  competitor  [236–243].  VGSC  activating  toxins  like  CTXs  (P-CTXs,  C-CTXs,  
I-CTXs) share a common receptor with brevetoxins (PbTxs), the binding site 5, which is located on the 
alpha subunit of the VGSC [95,108,109,146,148,191,243–247]. The binding activities of PbTxs and 
CTXs have been explored on brain, cardiac, and skeletal muscle sodium channel isoforms expressed in 
human,  rat,  marine  mammals,  marine  turtles  or  fish  neuronal  tissues  (for  a  review  see  Bottein 
Dechraoui et al. [191]). Comparative studies have shown that P-CTXs and C-CTXs are more potent to 
bind to site 5, with much higher affinity than PbTxs [33,146,148,188,246].  
The RBA designed for CTXs traditionally measures the binding competition between ciguatoxin in 
the  sample  and  a  [
3H]PbTx  standard  for  the  sodium  channel  receptor.  The  use  of  [
3H]PbTx  is  a 
necessity, as presently no tritiated CTXs is available. This is due to the infinite quantity of CTXs 
present in biological samples and the large quantities (several µ g) of pure toxins necessary for the 
synthesis of tritiated standards. Most authors cited above used [
3H]PbTx-3 and a few used [
3H]PbTx-9 
[95,96,184,248,249].  [
3H]PbTx-3  (15  Ci/mmol)  is  prepared  by  the  reduction  of  PbTx-2  with  [
3H] Mar. Drugs 2010, 8 
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sodium borohydride according to the method reported by Poli et al. [246]. Certified [
3H]PbTx-3 is 
commercially available on demand and the purity of the [
3H]PbTx-3 should be near 99% as determined 
by HPLC analysis and the stock solution should be kept at –80 °C . During the RBA, the concentration 
of [
3H]PbTx-3 may vary between 0.5-3 nM according to authors.  
The competitive experiment between CTXs and [
3H]PbTx for receptor binding has been carried out 
in test tube [33,34,45,69,146,148,184,250–252] or microplate [95–97,147,188,253]. 
Originally, rat  brain  membranes  were  used in RBA as  a  source  of VGSC. These  are prepared 
essentially following the protocol described by Dodd et al. [254]. A protein assay is used to determine 
the total synaptosomes concentration of each preparation of rat brain membrane. In order to determine 
the optimal synaptosomes concentration to be used in the RBA, different volumes of the preparation 
are put in the presence of constant tritiated brevetoxin ([
3H]PbTx) concentration. The concentration of 
synaptosomes  used  in  the  RBA  varies  from  40–150  µg   mL
-1  according  to  the  authors  
[33,34,45,69,95–97,146,147,184,188,250–253]. Synaptosomes are stored at –80 ° C for several weeks 
(up until six months). 
The optimal binding conditions are checked with total binding giving no more than 10% of the total 
radioactivity and with non specific binding lower than 30% measured in the presence of saturating 
concentration of PbTx-3. Specific binding is obtained when subtracting non specific binding from the 
total binding. Saturation experiments are performed using constant synaptosomes concentration and 
increasing  [
3H]PbTx-3.  Competitive  experiments  are  conducted  with  synaptosomes  concentrations 
chosen in the linear portion of the curve and constant [
3H]PbTx-3 with increasing concentration of cold 
competitor (non radiolabeled toxin or sample to test). The bound and unbound cold competitor are 
further separated by centrifugation or filtration, and the amount of  bound
 [
3H]PbTx-3 is measured 
using  a  liquid  scintillation  counter  in  a  given  volume  of  scintillation  cocktail  (some  scintillation 
cocktails  are  biodegradable  allowing  nonradioactive  wastes).  Then,  each  competitive  experiment 
yields a sigmoidal dose-response curve with binding parameter data such as the concentration of cold 
competitor  that  induces  50%  inhibitory  radiolabeled  binding  (IC50),  Kd  (dissociation  constant),  
Ki (inhibition constant), Hill slope, and Bmax (total binding sites). 
When testing for biological samples, calibration of the assay is generally performed by testing each 
RBA  with  a  known  amount  of  purified  toxins  (PbTxs  or  CTXs)  or  with  a  toxic  extract  of 
Gambierdiscus with a known concentration of P-CTX or C-CTX equivalent [34,69,148]. Practically, 
the IC50 value for the biological samples is expressed in equivalent of cells (cell mL
-1) for microalgae 
samples or gram of tissue (g mL
-1) for fish samples. The IC50 value obtained with standard toxin or 
calibrated sample is substituted by the IC50 obtained with the biological sample for the quantification 
of toxins expressed in g PbTx, P-CTX or C-CTX equivalents per gram of fish tissue or per cell for 
algal  samples  [33,34,69,95,147,148,249].  For  example,  RBA  toxicity  could  be  expressed  as  pg  
P-CTX-3C eqv/cell for Gambierdiscus samples, and as ng C-CTX-1 eqv g
-1 or ng P-CTX-3C eqv g
-1 
of flesh for fish tissues [33,34,69,148].  
When testing biological sample for specific toxins, as for any detection method, the matrix effect 
has to be taken into consideration. This is because the matrix is likely to contain components that may 
interfer with RBA by increasing non specific [
3H]PbTx-3 binding. These components could interact 
with the synaptosome membranes and disrupt the brevetoxin binding site on the sodium channel by 
altering protein structure or the interaction of the protein with other membrane component [250]. An Mar. Drugs 2010, 8 
 
1868 
increasing quantity  of a known  non-toxic sample is tested in  the  RBA competitive  experiment to 
determine the maximum quantity of a sample that does not cause matrix interferences according to the 
protocol of preparation used. For each type of biological sample, the limit of quantification (LOQ) 
should be established. This will help establish the range of sample concentration or quantity that has to 
be tested. Regarding P-CTXs, the LOQ of the RBA was estimated to be 15.5 fg P-CTX-3C eqv cell
-1 
for algal samples and 0.155 ng P-CTX-3C eqv g
-1 for fish samples [33].  
The RBA was successfully applied for monitoring programs on ciguatera risk in three islands of 
French  Polynesia:  Tubuai,  Raivavae  and  Nuku-Hiva  [33,34].  Indeed,  RBA  proved  to  be  a  very 
valuable, suitable and sensitive tool for detecting ciguatoxins in all stages of the trophic chain of 
ciguatera i.e., Gambierdiscus populations and fish from various trophic levels, thus providing early 
warning of increasing CFP toxicity in the trophic chain and in discriminating toxic areas from non-
toxic ones. In particular, results showed that herbivorous fishes in these study islands could display 
RBA values as high as in carnivorous fishes and even higher [33,34]. Such data has important sanitary 
significance for local populations of the Australes archipelago, given the higher local availability of 
this trophic group in the Australes as compared to data from other archipelagoes [34].  
Another common recommendation in CFP is to avoid the consumption of larger-size specimens 
[255,256]. However, in the case of these studies by Darius et al. [33] and Chinain et al. [34] no clear 
relationship was observed between RBA values and the size and weight of the 298 fish specimens 
tested in the Tubuai, Raivavae and Nuku-Hiva [33,34], suggesting that smaller-size specimens could 
be as dangerous as large ones. 
The RBA tool also proved useful for identifying fish species with a high risk of ciguatera. As an 
example, based upon RBA values, Tubuai and Raivavae Islands were shown to share the same high-
risk species, i.e., Scarus altipinnis, with RBA values of 4.52 and 5.58 ng P-CTX3C eqv g
-1 of flesh, 
respectively.  On  the  contrary,  the  high-risk  species  in  Nuku-Hiva  was  identified  as  Crenimugil 
crenilabis, for which maximum RBA values were found to be 2-3-fold higher than values recorded in 
Raivavae and Tubuai [33,34]. 
Finally,  results  yielded  by  RBA  in  Raivavae  were  found  generally  congruent  with  the  local 
population’s  knowledge  regarding  risky  species  and  areas,  suggesting  that  locally,  the  knowledge 
about ciguatera may not be scientifically complete but is functionally correct. 
Regarding CFP risk management, absence of a clear clinically effective dose harmful to humans 
greatly hampers the definition of a regulatory threshold for RBA. Using the same approach as the one 
described by Lewis for P-CTX-1B and C-CTX-1 [18,19], the clinically effective dose of P-CTX-3C 
was estimated to be >0.33 and 0.31 ng eqv P-CTX-3C g
-1 of flesh by Darius et al. [33], and Chinain et 
al.  [34]  respectively.  Further  RBA  analyses  were  conducted  on  11  leftover  fish  meals  that  had 
intoxicated  consumers  in  Tahiti  (French  Polynesia).  Symptoms  experienced  by  patients  included 
gastro-intestinal,  neurological  and  cardiovascular  disorders.  Toxic  samples  displayed  RBA  values 
ranging  from  0.38  to  2.69  ng  P-CTX-3C  eqv  g
-1  of  flesh  [257],  suggesting  the  relevance  of  the 
proposed precautionary threshold of 0.31 ng P-CTX-3C eqv g
-1 of flesh, especially with regards to 
individual susceptibility factors (e.g., heavy vs. occasional consumers, occurrence of previous CFP 
episodes, etc.).  
Despite the relevance of RBA tools, the need for specific equipment and licensing requirement for 
the use of radiolabeled components may lead to obvious limitations in the application of this assay. Mar. Drugs 2010, 8 
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Attempts to modify this assay to use label other than tritiated forms has led to the development of a 
competitive  receptor  binding  assay  based  upon  the  use  of  brevetoxin-B2  labeled  with  a 
chemiluminescent acridinium moiety [193]. The acridinium brevetoxin-B2 seems to be a promising 
alternative to the conventional radioactive ligand in order to avoid constraints associated with RBA.  
3.3.6.  Physico-chemical  analysis:  High  performance  liquid  chromatography  coupled  with 
spectroscopic (UV, FLD) or spectrometric (MS/MS) methods 
As  it  has  been  extensively  described  in  Section  3.1,  physico-chemical  analysis  of  CTXs  has 
involved HPLC since the 1960s, as purification methods were being developed for the isolation of the 
bioactive  compounds  (later  described  as  CTXs)  present  in  ciguateric  fish  and  responsible  for  the 
intoxications [126,127]. The first approach implemented to purify these compounds - and which is still 
used during the extraction procedures and the HPLC analytical steps - followed general rules applied 
for the purification of natural substances. Basically, these methods included the use of liquid/liquid 
partitions, open chromatography and HPLC, all taking into consideration the polarity of compounds. 
We present herein a review of the last 20 years of the available protocols on the chemical analysis of 
CTXs, addressing both chromatographical issues and detection strategies. 
3.3.6.1. High-performance liquid chromatography with UV detection 
Since most CTXs do not possess distinctive chromophor groups in their structures (e.g., series of 
alternating single and double bonds), they do not strongly absorb radiation over the UV/VIS region. As 
a consequence, detection of CTXs should be made at 210–215 nm, a poorly sensitive and non-selective 
range for detection. High-performance liquid chromatography coupled with UV detection (HPLC-UV) 
has  been  applied  extensively  as  a  strategy  for  the  isolation  of  CTXs  before  its  use  in  the 
characterization  of  CTXs  from  fish  tissues  and  dinoflagellate  extracts  
[29,45,94–96,99,102,134,135,197,258–260].  Legrand  et  al.  [135]  applied  HPLC-UV  with  isocratic 
mobile  phase  as  the  final  steps  for  isolation  of  CTX  from  viscera  of  moray  eels  (Gymnothorax 
javanicus).  Separation  involved  two  reversed-phase  columns:  LiChrosorb  RP-18  column  
(4.6 ×  250 mm, 10 and 5 µm) from Brownlee Lab and isocratic elution with different solvent mixtures 
methanol:water (80:20) or (90:10) and then with acetonitrile:water (65:35) [259]. Chromatography on 
samples of G. toxicus collected in French Polynesia was also reported on a Develosil ODS-7 column  
(8 ×  250 mm, Nomura Chemicals) using a linear gradient starting from acetonitrile:water (85:15) to 
(100:0). Slight modifications of such conditions involved the use of an Asahipak ODP-50 column 
(column  size  not  available)  and  isocratic  elution  with  acetonitrile:water  (75:25),  which  allowed 
isolation of up to 0.7 mg of P-CTX3C from 1,100 L of G. toxicus culture [99]. The same column was 
also  applied  for  the  isolation  of  two  analogs  of  P-CTX3C,  namely  2,3-dihydroxyCTX3C  and  
51-hydroxyCTX3C, by isocratic elution with acetonitrile:water (6:4) [197]. A similar approach was 
taken by Satake et al. [134] for the isolation of two additional toxins, firstly chromatographed together 
on a Capcell Pak C-8 (20 ×  250 mm, Shiseido) with a linear gradient from 65 to 100% acetonitrile and 
then further separated individually on a Asahipak ODP-50 column with isocratic elution at 45 and 75% 
acetonitrile for each toxin, respectively.  Mar. Drugs 2010, 8 
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The protocol applied for isolation of ciguatoxin-4A from G. toxicus cultures collected in Rangiroa 
Atoll (French Polynesia) followed a similar pattern. Isolation by HPLC-UV involved in this case an 
Asahipak  ODP-50  column  (10  ×   250  mm,  Showa  Denko)  and  linear  gradient  elution  with 
acetonitrile:water from (75:25) to (100:0), followed by chromatography in a Capcell pak C-8 column 
(4.6 ×  150 mm, Shiseido) with acetonitrile:water (65:35) and finally in an Asahipak ODP-50 column 
with acetonitrile:water (85:15) [29]. Isolation of 2,3-dihydroxyCTX3C from moray eel viscera also 
used  HPLC-UV  in  the  last  steps.  Extract  obtained  after  gel  permeation  chromatography  was 
chromatographed several times on columns Develosil ODS-7 (10 ×  250 mm) and Asahipak ODP-50 
(10  ×   250  mm)  by  linear  gradient  elution  with  acetonitrile:water  from  (60:40)  to  (100:0),  then 
isocratically on a Asahipak ODP-50 Shodex column with acetonitrile:water (65:35) [260]. 
A simplified procedure was proposed for fractionation of dinoflagellate and fish extracts based 
upon a C8 silica-based reverse phase column (4.6 ×  250 mm, 5 µ m; Altech Assoc.) [258] using a linear 
gradient  of  methanol:water  from  (50:50)  to  (100:0)  in  25  min.  A  standard  mixture  was  injected 
between  runs  to  check  the  stability  of  chromatographic  conditions  and  for  standardization  of  the 
retention times of the toxic fractions. The eluate was monitored by UV detection at 215 nm and the 
toxicity checked by MBA. The use of a C8 column instead of C18 seemed to be more adequate to 
achieve lower retention times and solvent consumption, especially for the less polar compounds that 
are usually present in dinoflagellate samples or herbivorous fish.  
The isolation of P-CTX-1, -2 and -3 from moray eels was achieved similarly on reverse-phase 
columns  LiChrocart  (Merck)  and  polymeric  PRP-1  (Hamilton)  with  isocratic  elution  with 
acetonitrile:water (50:50) for P-CTX-1 and (60:40) for P-CTX-2 and -3 [45]. Caribbean ciguatoxins  
C-CTX-1, C-CTX-2 and three other C-CTX-1-related compounds were isolated from the horseeye jack 
(Caranx latus) in a similar way with gel permeation columns, followed by PRP-1 (Hamilton) eluted 
with  acetonitrile:water  (1:1)  and  afterwards  with  LiChrocart  C18  (Merck)  eluted  with 
acetonitrile:water (2:1) [94,102]. The eluate was likewise monitored by UV at 215 nm and toxicity 
checked by MBA as in previous works. 
CTXs from the Indian Ocean (I-CTXs) were isolated from semi-purified extracts obtained by clean-
up with florisil and size-exclusion fractionation with Sephadex and TSK columns. HPLC-UV was 
applied isocratically on a LiChrospher 100 RP-18 (4 ×  250 mm, 5 µm; Merck) with methanol:water 
(90:10) at 1 mL min
-1, then with methanol:water (88:12) in the same column and finally on a PRP-1 
column (4 ×  150 mm, Hamilton) eluted with acetonitrile:water:isopropanol (80:19:1). The eluant was 
monitored at 215 nm and toxicity tested by MBA and radiolabeled ligand binding assay (RBA) with 
tritiated brevetoxins (PbTx-3 or PbTx-9) [95,96]. 
In summary, the ultimate isolation of CTXs from pre-purified extracts obtained after liquid-liquid 
extraction,  solid-phase  extraction,  and  size-exclusion  chromatography  were  achieved  by  reversed-
phase HPLC-UV with C18, C8 and polymeric columns. Isocratic or linear gradients based mainly on 
acetonitrile:water binary systems ranged from 50:50 to 100:0 depending on the polarity of congener, 
which  may  be  put  in  a  hierarchical  order  according  to  the  source  (carnivorous  >  herbivorous  > 
dinoflagellate). 
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3.3.6.2. High-performance liquid chromatography with fluorescence detection 
The presence of a primary hydroxy group at the side chain of the P-CTX-1 molecule suggested that 
the  toxin  could  be  derivatized  into  a  fluorescent  ester  being  suitable  for  high-performance  liquid 
chromatography with fluorescence detection (HPLC-FLD). The strategy proposed by Goto et al. for 
derivatization  of  hydroxysteroids  [261],  based  upon  the  commercially  available  reagent  
1-anthroylnitrile (i.e., anthrylcarbocyanide), was applied with this aim, achieving a detection level of  
1 ng [262]. The coupling efficiency for the derivatization step was estimated at 81 ±  4% [263]. Since a 
primary  hydroxyl  group  may  be  often  present  in  compounds  from  such  biological  matrices,  an 
additional clean-up was required after derivatization by solid-phase extraction with a Sep-pak silica 
cartridges (Millipore). The HPLC-FLD conditions were adopted from those previously proposed for 
analysis of pectenotoxin-1 [264], using isocratic elution with 85% acetonitrile on a Develosil ODS-5 
(4.6 ×  250 mm, Nomura Chemistry) column at 30 ºC  and 1 mL min
-1, and with the fluorescence 
detector set at 365 and 465 nm wavelengths for excitation and emission, respectively [92,265]. Such a 
procedure was successfully applied to samples of G. toxicus and to different carnivorous fish species, 
including G. javanicus, Lutjanus bohar, Plectropomus leopardus and Epinephelus fuscoguttatus. The 
applicability of this method was also demonstrated for P-CTX-2, P-CTX-3, 2,3-dihydroxyCTX3C; in 
this case changing the isocratic elution to acetonitrile:water (95:5) [17]. The method showed good 
linearity, which contributed to obtaining accurate results. Applying very similar conditions to 11 minor 
CTXs isolated from carnivorous fish demonstrated that some congeners lacked the primary hydroxyl 
group,  and  therefore  did  not  derivatize  (e.g.,  P-CTX3C).  The  derivatization  protocol  was  also 
investigated  using  carbonyl  azides  or  carbonyl  nitriles  of  coumarin  derivatives  [266];  the  reagent  
7-diethylaminocoumarin-3-carbonyl azide provided the best quantum yields and fewer accompanying 
peaks in the chromatogram. The main advantage of using aminocoumarins instead of other reagents for 
derivatization is that a fluorescent chromophor and a nitrogen-containing moiety can be introduced in a 
single step, which enhanced the signal obtained in mass spectrometry analysis. HPLC-FLD detection 
was performed in this case at 238 and 455 nm for excitation and emission wavelengths, respectively, 
providing a limit of detection between 0.5–1.0 ng.  
Another HPLC-FLD method was reported using continuous flow, post-column derivatization of the 
chromatographically separated toxins from G. toxicus [267]. Alkaline oxidation with periodic acid and 
ammonium  hydroxide  was  used  to  form  fluorescent  derivatives  in  a  similar  way  to  that  used  for 
analysis  of  PSP  toxins  [268,269].  Nevertheless,  the  authors  concluded  that  it  was  not  possible  to 
achieve quantifiable results using standard addition techniques, and analytical precision was much 
poorer  than  that  obtained  with  the  MBA.  These  facts  may  be  explained  by  results  from  further 
separation by size exclusion chromatography, which revealed a molecular weight of toxic fraction 
around 38,000–40,000 Da. Such a difference suggests that they are unlikely to be related to CTXs.  
In summary, despite the fact that HPLC-FLD methods are usually considered highly sensitive, the 
routine applicability to CTXs determination within monitoring programs is limited. CTXs are very 
potent  toxins  causing  poisoning  even  at  very  low  amounts.  According  to  reported  events,  it  was 
initially estimated that levels as low as 35 ng CTX/100g were toxic [17]. Taking into account the limit 
of detection of 0.5–1 ng on-column, such toxic levels might be achieved from a 50–100 g sample in 
the case that only P-CTX-1 is present. However, according to the safety limits recently reported of Mar. Drugs 2010, 8 
 
1872 
0.01 ng g
-1 for P-CTX-1 and 0.1 ng g
-1 for C-CTX-1 [24], at least 50 and 500 g would be needed for 
analysis of C-CTX-1 and P-CTX-1, respectively. Additionally, at least 23 and 12 different congeners, 
which could contribute to the total toxicity responsible of the ciguatera fish poisoning, have been 
already  described  for  P-CTXs  [227]  and  C-CTXs  [97],  respectively.  In  carnivorous  fish,  it  was 
estimated that nearly 60–80% of ciguatoxicity in MBA was related to CTX-1B (P-CTX-1), while 25% 
corresponds to other derivatizable CTXs [263]. Other congeners that lack the primary hydroxyl group 
may  be  present  in  samples,  especially  in  herbivorous  fish,  making  this  approach  unsuitable  or 
uncertain to efficiently protect public health. 
3.3.6.3. High-performance liquid chromatography with mass spectrometry detection 
The use of mass spectrometry (MS) for the analysis of ciguatoxins was already considered during 
the first stage of characterization and structural elucidation of congener structures, mainly by using fast 
atom bombardment (FAB) as an ionization technique. The introduction of ionspray (IS) as ion source 
for MS analysis of CTXs was reported by Lewis et al. in 1994 [270]. The variation on the ion source 
conditions applied, mainly the orifice potential led to measure the molecular and pseudomolecular ions 
of P-CTX-1 in different m/z intensities: 1,111.8 for [M + H]
+, 1,133.8 for [M + Na]
+, 1,129.8 for  
[M + H + H2O]
+ and losses of up to five water molecules (m/z: 1,094, 1,076, 1,058, 1,040 and 1,022). 
The mass spectrometric analysis obtained with IS provided similar mass spectra and fragmentation 
patterns to those reported previously with FAB. The technique reached a limit of detection of 1 ng of 
pure CTX-1, equivalent to that reported for HPLC-FLD. However, severe ion suppression effects were 
found when a crude lipid extract of fish was spiked with P-CTX-1 at an equivalent of 1.5 ng g
-1 flesh. 
Nevertheless, this was the first attempt to provide a simple, sensitive and confirmatory HPLC-MS 
coupled technique.  
HPLC-MS analysis of highly purified extracts from the viscera of ciguateric moray eels (Lycodontis 
javanicus) allowed determination of up to 14 P-CTXs congeners at m/z of 1,095.7 (two), 1,111.6 (six) 
or 1,127.7 (six), including dominant ions for P-CTX-1, -2 and -3 [271]. In addition to the protonated 
species,  each  of  these  ciguatoxins  gave  rise  to  prominent  ammonium  [M  +  NH4]
+  and  sodium  
[M + Na]
+ adducts. It was noted that acetonitrile:water gradient modified with 1 mM ammonium 
acetate provided better results than modification with 0.1% TFA, as well as the use of turbo-assisted 
HPLC-MS,  which  provided  a  20-fold improved signal  over conventional HPLC-MS. The limit  of 
detection allowed easy detection of 4 ng g
-1 P-CTX-1 in fish flesh. Adducts of sodium, ammonium, or 
even  potassium,  as  well  as  ions  resulting  of  up  to  five  water  losses  have  also  been  reported  for  
C-CTXs  [94].  This  characteristic  pattern  proved  to  be  very  successful  for  identification  of  new  
CTXs congeners. 
HPLC-MS  was  applied  for  the  characterization  of  12  C-CTXs  accumulated  by  horse-eye  jack 
(Caranx latus) that was previously purified with size-exclusion chromatography with a TSK column 
(Toyopearl) [97]. In this case, an HP 3300 HPLC pump was coupled with a hybrid quadrupole/time of 
flight  analyzer  API  Qstar  Pulsar  (PE-Sciex).  Ions  corresponding  to  [M  +  NH4]
+,  [M  +  H]
+  and  
[M + H - H2O]
+ and [M + H - 2H2O]
+ were present in significant intensities when formic acid was used 
as solvent modifier. On the contrary, lower intensities and absence of [M + NH4]
+ pseudomolecular ion 
was obtained with TFA. Besides, formic acid also improved the base peak chromatogram and the MS Mar. Drugs 2010, 8 
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spectrum by five-fold compared to TFA, and consequently seemed to be more adequate for CTX 
ionization. Reversed-phase separations were more efficient on a Zorbax C3 (2.1 ×  150 mm, Agilent) 
than on an Aquapore C18 RP 300 (1 ×  50 mm), especially to separate closely eluting congeners. 
Chromatographic gradient was performed with acetonitrile:water (both modified with 0.1% formic 
acid). The analysis of toxic fractions led to  determination of five new CTX congeners at m/z for  
[M + H]
+: 1,159.6, 1,143.6, 1,157.6, 1,127.6; plus several isomers of them and of the C-CTX-1, not 
previously reported. The same conditions allowed determination of some of these congeners in other 
fish species such as grey snapper (Lutjanus griseus), grouper (Serranidae) and a black jack (Caranx 
lugubris)  [98],  as  well  as  in  barracuda  (Sphyraena  barracuda),  where  ciguatoxins  and  also  other 
hydroxyl-polyether compounds likely related to brevetoxins were identified [147]. 
I-CTXs were first reported by Hamilton et al. [96], isolated from red bass (Lutjanus bohar) and red 
emperor  (Lutjanus  sebae)  fishes,  and  characterized  by  HPLC-MS  in  a  similar  way  to  previously 
reported  for  C-CTXs  [97,98,147],  with  the  exception  of  the  chromatographic  conditions.  The 
conditions were modified to isocratic elution on a Zorbax 300SB (2.1 ×  150 mm, 3.5 µm, Agilent) 
with acetonitrile:water:isopropanol (80:19:1) modified with 5 µ M ammonium acetate or 0.1% formic 
acid. The molecular ion of I-CTX matched with that of C-CTX at m/z 1,141.6, though relative ion 
abundances  among  molecular  and  pseudomolecular  ions  differed,  with  the  pseudomolecular  ion  
[M + H - H2O]
+ the most abundant for the Indian congener. Further studies on red emperor led to 
characterization  of  three  additional  Indian  ciguatoxins  (I-CTX-2  to  -4).  I-CTX-1  and  -2  showed 
indistinguishable masses from C-CTX-1 and ca. 60% of the toxic potency of P-CTX-1. The spectra 
patterns  involved  the  typically  associated  ions,  namely  [M  +  H]
+,  [M  +  Na]
+,  [M  +  NH4]
+,  
[M + H - nH2O]
+, with n from 1 to 3. It was presumed that I-CTX-1 and -2 may arise from different 
dinoflagellates and then oxidized to I-CTX-3 and -4. 
A  further  work  from  Lewis  et  al.  reported  coupling  of  HPLC  with  tandem  mass  spectrometry 
(MS/MS)  [272].  The  MS/MS  was  tuned  by  direct  infusion  of  pure  CTX  standard  in  50% 
acetonitrile:0.1% aqueous TFA. Product ions for MRM transitions were optimized for the loss of NH3 
from  the  dominant  [M+NH4]
+  pseudomolecular  ion  and  additional  losses  of  up  to  three  water 
molecules.  Thus,  transitions  were  (m/z):  1,128.7  >  1,094.0/1,076.0/1,058.0  for  P-CTX-1  and  
1,158.6 > 1,123.6/1,105.6 for C-CTX-1. The method provided a linear response within the working 
range and improved sensitivity: the limits of detection were as low as 0.04 and 0.1 ng g
-1 fish flesh for  
P-CTX-1  and  C-CTX-1,  respectively.  Chromatographic  conditions  used  a  reversed-phase  column 
Vydac (2.1 ×  250 mm, 5 µm; Separation Group) eluted with linear gradient acetonitrile:water modified 
with 0.05% TFA. 
An  1100  HPLC  (Agilent)  coupled  to  a  4000  QTRAP  hybrid  mass  spectrometer  (Applied 
Biosystems) was applied for the confirmation of P-CTX-1 and C-CTX-1 on the basis of mass and 
retention  times  compared  with  reference  materials  [119].  Working  under  triple  quadrupole  mass 
spectrometry basis (LC-MS/MS), a highly specific detection was achieved. For C-CTX-1, three MRM 
transitions  were  selected  using  the  pseudomolecular  ion  [M+H-H2O]
+  as  precursor  ion  
(m/z:  1,123.5  >  1,105.6/1,087.6/1,069.6),  and  the  response  added.  For  P-CTX-1,  two  groups  of 
transitions were monitored and the response added. The first took the molecular ion [M + H]
+ as 
precursor ion (m/z: 1,111.6 > 1,093.6/1,075.6/1,057.6) and the second was based upon the ammonium 
adduct [M+NH4]
+ (m/z: 1,128.6 > 1,093.6/1,075.6/1,057.6). Turbo ion spray conditions were identical Mar. Drugs 2010, 8 
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for nebulizer gas (50 psi), turbo gas (50 psi), temperature (400 º C), curtain gas (20 psi), and IS voltage 
(+5  kV).  Collision  energy  was  specifically  optimized  for  each  transition  and  ranged  between  
15–37 eV. Chromatographic conditions used reversed-phase Luna C8(2) column (2 ×  150 mm, 5 µ m; 
Phenomenex) and programmed linear gradient with acetonitrile:water modified with 0.1% formic acid. 
This procedure was successfully applied, in combination with cell-based assays, as a confirmatory 
technique in the study of CFP outbreaks since 1999. 
Recently, improved HPLC-MS/MS methods have been reported by Australian groups. Lewis et al. 
[124] reported HPLC-MS/MS analysis following a ciguatoxin rapid extraction method from 2 g fish 
flesh sample. A limit of quantification of 0.1 ng g
-1 was achieved, which was suitable to confirm 
suspect ciguateric fish in the Pacific Ocean [124]. In this case, the HPLC system was equipped with a 
Luna  C18  column  (2.1  ×   250  mm,  5  µm)  and  a  guard  column  (4  ×   2.1  mm,  5  µm),  both  from 
Phenomenex. The program gradient was performed with a binary mobile phase system consisting on 
95%acetonitrile:water modified with 2 mM ammonium formate and 0.1% formic acid. The MS/MS 
systems were triple quadrupole API 2000 and API 4000 QTRAP (Applied Biosystems), the latter more 
sensitive. The three MRM transition pairs for P-CTX-1 were based upon the fragmentation of the 
pseudomolecular ion [M + NH4]
+, with subsequent loss of ammonia and successive losses of water  
(m/z: 1,128.7 > 1,093.7/1,075.7/1,057.7). Soon after, Stewart et al. presented a modification of the 
rapid extraction method proposed by Lewis et al. with HPLC-MS/MS analysis of P-CTX-1, -2 and, -3 
in ciguatera-suspect fish [125] (Figure 8). The chromatographic system consisted of Prominence LC 
(Shimadzu Corp.) equipped with a Gemini C6-phenyl column (2 ×  50 mm; Phenomenex) and an 
AB/Sciex API4000Q (AB/MSD Sciex). Acetonitrile:water-based gradient, similar to other previously 
reported and equally modified with 2 mM ammonium acetate and 0.1% formic acid, was used. The 
MRM transitions for MS/MS detection were based upon those previously reported [124], and extended 
to  the  analysis  of  CTX-2  and  -3  (m/z:  1,128.7  >  1,093.7/1,075.7/1,057.7  for  P-CTX1  and  
1,112.7 > 1,077.6/1,059.6/1,041.6 for P-CTX-2 and -3).  
Similar  conditions  to  previous  work  for  HPLC-MS  [96,97]  and  for  HPLC-MS/MS  [124]  were 
applied for confirmation of P-CTXs as causative agents in samples of toxic fish and post-mortem 
human liver after a fatal human poisoning [273]. 
Several works have focused on the analysis of CTXs present in dinoflagellate cultures. Apart from 
those previously mentioned that focused on isolation and characterization of congeners using HPLC 
and further FAB-MS off-line, the development of coupled HPLC-MS/MS methods have motivated 
further studies on toxin production by species of the genus Gambierdiscus.  
Roeder et al. [122] conducted a series of studies on cultured strains of Gambierdiscus from different 
origins. In this  case, chromatographic separation  was performed  on Shimadzu  HPLC system with 
Hyperclone C8 column (2 ×  50, 3 µm) and guard column, both from Phenomenex. Separation was 
achieved  with  a  gradient  elution  program  of  acetonitrile:water  modified  with  5  mM  ammonium 
formate.  MS/MS  detection  was  carried  out  by  an  API  365  MS/MS  triple  quadrupole  (Applied 
Biosystems) with Turbo Ion Spray as ion source. MRM transitions were acquired in this case both in 
positive  and  negative  mode.  To  the  best  of  our  knowledge,  this  is  the  only  work  in  which  CTX 
determination  has  been performed  in  negative  mode.  According to  the  authors, the  application  of 
negative polarity provided even more sensitivity than the positive one. However, due to the lack of Mar. Drugs 2010, 8 
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proper analytical standards, additional toxicological or functional studies should have been performed 
on LC-fractions to confirm their activity. 
Table 2. Principal ciguatoxin congeners analyzed by HPLC-MS with their corresponding 
molecular ions masses. 
Name  Alternative name  Molecular ion [M + H]
+  Source  References 
Pacific ciguatoxins 
P-CTX-1  CTX1B  1111.6  Carnivorous fish   [45,271] 
P-CTX-2  CTX2A2; 52-epi-54-deoxyCTX  1095.5  Carnivorous fish   [45,271,274] 
P-CTX-3  CTX2B2; 54-deoxyCTX  1095.5  Carnivorous fish   [45,271] 
49-epi-CTX-3C  CTX-3B  1023.6  G. toxicus   [69,99] 
M-seco-CTX-3C    1041.6  G. toxicus   [69,99] 
CTX-3C    1023.6  G. toxicus   [99,122] 
2,3-dihydroxyCTX-3C  CTX-2A1  1057.6  Carnivorous fish/G. toxicus   [197,122] 
51-hydroxyCTX-3C  CTX-2C1  1039.5  Carnivorous fish   [197] 
CTX-4B  GT-4B  1061.6  G. toxicus Herbivorous fish   [29,122,227] 
52-epi-ciguatoxin-4B  CTX-4A; GT-4A  1061.6  G. toxicus   [100,122,227] 
Caribbean ciguatoxins 
C-CTX-1    1141.6  Carnivorous fish   [94,97,98,102,147,272] 
C-CTX-2 
 
56-epi-C-CTX-1  1141.6  Carnivorous fish   [94,97,98,102,147] 
C-CTX-1127    1127.6  Carnivorous fish   [97,98,147] 
C-CTX-1143    1143.6  Carnivorous fish   [97,98,147] 
C-CTX-1157    1157.6  Carnivorous fish   [97,98,147] 
C-CTX-1159    1159.6  Carnivorous fish   [97,98,147] 
Indian ciguatoxins 
I-CTX-1    1141.6  Carnivorous fish   [96] 
I-CTX-2    1141.6  Carnivorous fish   [95,96] 
I-CTX-3    1157.6  Carnivorous fish   [95,96] 
I-CTX-4    1157.6  Carnivorous fish   [95,96] 
Figure 8. Total ion chromatogram for a fish sample extract containing P-CTX-1 (3.83 min, 
0.8  mg/kg),  P-CTX-2  (5.01  min,  1.1  mg/kg)  and  P-CTX-3  (5.35  min,  1.4  mg/kg). 
Reprinted from [125], reprinted with permission from Elsevier. 
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Ciguatoxins from cell pellets obtained by culturing several strains of Gambierdiscus isolated from 
Rarotonga lagoons were analyzed using an UPLC Acquity system (Waters Corp.) equipped with a 
BEH-C18 column (50 ×  1 mm) packed with 1.7 µm particle size (Waters) and coupled to a Quattro 
Premier triple quadrupole MS (Waters). The mobile phase consisted of a linear gradient from water to 
acetonitrile  with  0.1%  formic  acid.  The  analysis  was  performed  in  positive  mode  for  congeners  
CTX-3B, -3C, -4A and -4B. Multiple Reaction Monitoring (MRM) transitions monitored molecular 
ions [M + H]
+ for precursor ions and then the fragments at m/z 165 and 125 for product ions, according 
to the product ion spectra obtained intra-laboratory. The use of such alternative product ions indicates 
that the maximum sensitive and selective in MRM analysis should be investigated for each type of 
instrumentation  by  tuning  the  MS  with  proper  CTXs  standards.  The  advantages  of  using  ultra-
performance chromatography and  separation  on sub-2 µm particle size columns  include  enhanced 
efficiency, sensitivity and high-throughput analysis. In this case, retention times ranged from 3.45 to 
4.00 min for the congeners analyzed, and the limit of detection that was estimated with non-certified 
standard solution was 10 pg loaded on column [70]. None of these congeners were detected in the 
cultured strains, even though they showed toxicity to Neuro-2A cells. 
The  production  of  CTXs  by  several  strains  was  also  investigated  for  different  species  of 
Gambierdicus isolated in French Polynesia by MBA, RBA and HPLC-MS/MS [69]. After purification 
and  fractionation  by  low  and  high  pressure  liquid  chromatography,  HPLC-MS  analyses  were 
conducted on an Agilent 1100 HPLC equipped with a Luna C18(2) (2 ×  50 mm, 5 µm; Phenomenex). 
The elution was isocratic 70 or 80% acetonitrile modified with 0.1% or 0.3% acetic acid; and delivered 
to an MSD Sciex API 4000 triple quadrupole (Applied Biosystems). Interestingly, to the best of our 
knowledge, this is the only report in which two alternative ion sources (Turbo Ion Spray, TIS and 
Atmosphere Pressure Chemical Ionization, APCI) were tested. APCI was shown to be more efficient 
in  promoting  the  molecular  ion  [M  +  H]
+  and  avoiding  [M  +  Na]
+  adducts.  A  wide  variety  of 
congeners  were  determined,  though  P-CTX-3C,  -3B,  -4A,  -4B  and  M-seco-CTX-3C  added  up  to  
97–98%  of  the  total  CTXs  found  in  two  G.  polynesiensis  clones.  Interestingly,  the  toxin  profiles 
seemed  to  be  characteristic  for  each  clone  and  their  total  toxin  content  increased  with  the  age  
of culture. 
During the course of this study, a potential mistake on the molecular ion associated to P-CTX-3C 
firstly  reported  by  Satake  et  al.  [99]  has  been  identified.  Several  publications  and  reviews  have 
assigned an m/z value for molecular ion [M + H]
+ of 1,045 for P-CTX-3C [20,122,275,276]. However, 
according to the original reference [99], this m/z value seems more likely to be that of the sodium 
adduct  [M  +  Na]
+,  which  can  be  promoted  in  the  analysis  of  algal  samples  with  relatively  high  
salt content.  
In  summary,  HPLC-MS  and  HPLC-MS/MS  have  proved  to  be  extremely  useful  for  the 
identification and  characterization of new CTXs  congeners  around the  world. Moreover, forefront 
instrumentation  available  over  recent  years  has  provided  enhanced  sensitivity  and  selectivity  by 
measuring  accurate  masses  or  a  series  of  fragment  ions  according to  characteristic  patterns.  Such 
advances  have  opened  a  new  era  of  application  of  mass  spectrometric  detection  methods  for 
unequivocal confirmation of ciguatera suspect-fish. However, taking into account the safety limits 
recently  reported  (0.01  ng  g
-1  and  0.1  ng  g
-1  for  P-CTXs  and  C-CTXs,  respectively 
[18,19,24,119,120]),  it  seems  that  HPLC-MS  methods  are  still  limited  when  needed  for  accurate Mar. Drugs 2010, 8 
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quantitative  results  from  very  close  borderline  samples.  Improvements  in  instrumentation  and  in 
sample preparation will allow the routine application of HPLC-MS to overcome some matrix effects 
from fish samples and decrease the limits of detection and quantification. Additionally, combination 
with a screening technique may also provide improvements in sample throughput.  
4. Perspectives to Confront the Onset of Ciguatera in Europe 
4.1. Ciguatera in Europe 
Cases  of  CFP  in  Europe  are  usually  associated  to  ciguateric  seafood  imported  from  ciguatera-
endemic areas or to CFP in travelers returning from endemic CFP areas [5–8]. In 2005, Perez-Arellano 
et al. [9] reported for the first time the occurrence of CFP in the Canary Archipelago (Macaronesia). In 
January 2004, a 26-kg amberjack (Seriola rivoliana) was captured along the Coast of  the Canary 
Island, filleted and consumed by five family members. Symptoms appeared between 30 minutes and 
28 h after consumption and resolved after several weeks, but recurred intermittently with a lower 
intensity  for  several  months.  The  symptoms  exhibited  were  gastrointestinal,  neurological, 
cardiovascular and general symptoms typical of CFP such as reversal of hot and cold sensation, though 
the affected family members did not require hospitalization [9]. Analysis of the fish portion gave 
positive results using an immunobead assay (not identified) and presence of CTXs was confirmed 
using Neuro-2a cell based assay as well as LC-MS/MS analysis. CTX content was low and estimated 
at  1.0  ng  g
-1.  Caribbean  CTX-1  was  identified  by  LC-MS/MS  in  addition  to  two  non-identified  
CTX-like compounds [9]. This case of CFP was the closest confirmed case occuring to Europe with 
evidenced presence of CTXs (LC-MS/MS) and the first case of intoxication from temperate waters of 
the Eastern Atlantic Ocean. 
Epidemiological data have reported in the past various cases of ichtysarchotoxism in the Eastern 
Mediterranean  Sea  (Israel  coasts)  after  consumption  of  rabbitfish  (Siganus  luridus)  in  1971–1972 
[277] and in 2002 [278], saupe (Sarpa salpa) in 1988 [279] and other edible fish (Siganus spp.) in 
2004–2007 [280,281] which were tentatively described as CFP. In the latter case [281], a membrane 
immunobead assay tested on various fish samples gave a positive response, but the presence of CTXs 
was not confirmed using RBA, chemical or toxicological studies [281]. Moreover, misinterpretation of 
the CFP-induced saupe consumption [279] with Caulerpa poisoning was proposed by Chevaldonné  
[37]. De Haro and Pommier [282] recently distinguished CFP from ichthyoallyeinotoxism caused from 
consumption of saupe that is probably associated to Caulerpaceae [37]. Possible misdiagnoses of CFP 
with other forms of ichthyosarchotoxism have raised the necessity to confirm the presence of CTXs in 
the food or blood of affected patients in order to confirm the occurrence of CFP within these areas. 
Recent epidemiological data reported two outbreaks  of ichthyosarchotoxism diagnosed  as  CFP, 
which occurred in 2007 and 2008 in Madeira Archipelago (Eastern Atlantic Ocean) 260 miles north of 
the Canary Islands Archipelago [10]. In the first case, a total of six patients were intoxicated after 
consumption  of  various  fish  species  i.e.,  Seriola  sp.,  Sparisoma  credence,  Serranus  atricauda, 
Bodianus scrofa, Balistes capriscus and Pagrus pagrus captured at the Salvage Islands. Neurological 
symptoms lasted between 0.5 and 1.5 months. The second case concerned intoxication of 11 crew-
members after the consumption of a 30 kg fish of the genus Seriola, captured at the Big Salvage Mar. Drugs 2010, 8 
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Island. Neurological and gastrointestinal symptoms, lasting for one month, appeared as early as four 
hours after fish ingestion and required hospitalization of affected people. Presence of CTXs could not 
be confirmed in the fish flesh. In 2009, a 71 kg Seriola dumerili was fished at the Salvage Islands and 
one portion was tested using the ―Cigua-Check Fish poison Test‖ (Oceanit). The immunoassay tested 
positive,  but  presence  of  CTX-like  compounds  has  not  yet  been  confirmed  using  chemical, 
pharmaceutical nor toxicological methods [10].  
More recently, among a total of 64 samples collected along the coast of Cameroon, three were 
tested toxic using the Neuro-2a CBA [151]. This time, presence of CTXs compounds in toxic samples 
was further supported by LC-MS analysis, confirming a ciguatera outbreak along the coast of the 
Eastern Atlantic Ocean. 
4.2. Gambierdiscus species in the Mediterranean Sea and Macaronesian waters (Canary Islands) 
In 1948, a dinoflagellate reported as Goniodoma sp. [283] was detected in a sample collected from 
Boa Vista Island (Cabo Verde). The detailed description given for this dinoflagellate coincides very 
well with the original description of Gambierdiscus toxicus published almost two decades later [28]. 
Therefore  it  is  likely  that  Silva’s  description  of  Goniodoma  sp  may  actually  constitute  the  first 
evidence of the presence of the genus Gambierdiscus in Eastern Atlantic Ocean waters. In 2004, Fraga 
et al. reported for the first time the presence of Gambierdiscus sp. in the Canary Islands, at a latitude 
12º   N  of  Cabo  Verde  [15].  Based  upon  the  recent  revision  of  the  taxonomy  of  the  genus 
Gambierdiscus by Litaker et al. [73], morphological and molecular analyses are currently in progress 
on Gambierdiscus clones isolated from the Canary Islands, in order to specify whether these Eastern 
Atlantic clones should be placed in a separate species group. Regarding the toxicity of the Canary 
Islands  isolates,  recent  studies  conducted  on  Gambierdiscus  cells  crude  extracts  revealed  high 
unspecific  toxicity  on  the  Neuro-2a  CBA  [192],  probably  associated  to  a  high  MTX-like  activity 
[137,284]. No data are currently available regarding CTX production.  
As the first description of Gambierdiscus spp. in the Canary Islands waters also coincided in time 
with both ciguatera outbreaks reported, the issue of a possible impact of Gambierdiscus blooms on 
public health and local fisheries in this area should also be considered. So far, there is no direct proof 
that these events are related, as amberjack can migrate and could become toxic far from the Canary 
Islands where it was captured. Moreover, other groups of benthic dinoflagellates such as Ostreopsis, 
Coolia, and Amphidinium commonly present in ciguateric biotopes were also detected epiphytically on 
benthic macroalgae in Tenerife, along with Gambierdiscus cells. Very recently, additional strains of a 
yet undetermined but different Gambierdiscus species have been isolated in the Canary Islands [285]. 
This same observation also applies to Gambierdiscus populations reported in 2007 in Crete Island 
(Greece) [14], which constitutes the first record of these genus in the Mediterranean Sea. This finding 
conduced the re-examination of archival material from Crete Island, and after additional study of fixed 
samples  Gambierdiscus  spp.  could  be  confirmed  as  present  since  2003  [13].  Although  the 
morphological descriptions conducted at that time on this material led to the conclusion that it fitted 
well with the ―G. toxicus type‖ as defined by Richlen et al. [72], it was not assigned to a species, as the 
taxonomy of the genus remained unclear [13]. Morphological and molecular analyses are currently 
underway in the light of the newly revised taxonomy of this genus [73] in an attempt to clarify the Mar. Drugs 2010, 8 
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identity and the origin of these Cretan isolates. As for their toxic potential, preliminary toxicological 
studies based upon the Neuro2a-CBA revealed the lack of production of MTX-like compounds in in 
vitro conditions [284]. They also tested negative with MBA [12]. These data are consistent with the 
observation that the presence of Gambierdiscus in Crete has not coincided nor has been associated 
with the occurrence of CFP cases since 2003. However, it raises questions about a potential risk of 
CFP within this area, and to a larger extent within the Mediterranean Sea. 
The  identification  of  tropical  and  subtropical  representatives  of  potentially  toxic  benthic 
dinoflagellate genera, such as Ostreopsis and Gambierdiscus, in the Eastern Atlantic Ocean has posed 
the question of the impact of climate change on the spreading of microalgae to more temperate waters 
[286]. This hypothesis is in accordance with the ―tropicalization scenario‖ of the Mediterranean Sea 
proposed by Bianchi [287], taking also into account the increase of sea surface temperature [288]. The 
detection  of  Gambierdiscus  spp.  for  the  first  time  in  the  Mediterranean  Sea  [14],  along  with  the 
increasing records of blooms of Ostreopsis spp. in the area [11,12,289,290–293], are consistent with 
the  aforementioned  hypotheses.  As  in  the  case  of  other  aquatic  organisms,  the  presence  of 
Gambierdiscus in the Eastern Mediterranean Sea raises the issue of its origin; lessepsian migration 
(through  the  Suez  Canal)  or  invasion  via  the  Strait  of  Gibraltar  are  general  possible  hypotheses, 
however,  further  phylogenetical,  taxonomical  and  toxicological  analyses  will  shed  light  on 
Gambierdiscus  phylogeography.  Anthropogenic  introduction  of  the  species  cannot  be  excluded, 
although there is no evidence or objective observation that may suggest such an origin. The fact that 
ciguatoxins  from  the  Pacific  are  different  from  those  from  the  Caribbean  [94–98]  might  be  an 
indication that  since Gambierdiscus and  Ostreopsis share similar ecology, these genera may  have 
similar  biogeographical  patterns.  Distinct  biogeographical  patterns  are  observed  among  Ostreopsis 
species from the Indo-Pacific Ocean and those of the Atlantic Ocean including the Mediterranean Sea 
[294];  the  two  warm  water  realms  that  became  separated  as  a  consequence  of  the  closure  of  the 
Panama Isthmus. Despite accumulating evidence, the possibility that increased records may, in part, 
reflect an intense research in the field of marine benthic dinoflagellates during the last years should not 
be neglected [14]. In respect to the distribution of Gambierdiscus spp. and possible risk associated to 
ciguatera,  one  may  not  forget  that  toxicity  studies  on  several  Gambierdiscus  strains  of  different 
latitudinal distribution in the western Atlantic showed that in the Northern hemisphere, Gambierdiscus 
strains  located  at  higher  latitudes  (Bahamas)  were  less  toxic  than  those  at  lower  latitudes  
(Caribbean) [295]. 
There is increasing discussion about the link between climate variability and harmful algal blooms, 
(i.e., geographical expansion of toxic benthic dinoflagellates, as a possible consequence of climate 
change), and its impact on human health (e.g., ciguatera, palytoxin-like poisonings) [11,78,296–298]. 
A survey in the South Pacific [78] particularly aimed to verify the link between ciguatera and climate 
change. This study suggests a model that contrasts the simple link between sea surface temperature 
increments with occurrence of CFP, although sea surface conditions need to be favorable long enough 
to generate enough load of ciguatoxins in ecosystems for occurrence of CFP in human populations. 
Moreover,  accumulation,  metabolism  and  detoxification  kinetics  may  be  altered  in  fish  vectors  in 
response to variation of ambient temperature, as described for tetrodotoxins [299] or organic pollutants 
[300]. Diversity of fish species as toxin vectors may also be altered in response to different climatic 
conditions [301]. Global warming is the explanation for the increasing reports of tropical fishes at Mar. Drugs 2010, 8 
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higher latitudes [302]. Some of these fishes, which become toxic in ciguateric areas, could expand CFP 
to  higher  latitudes  by  their  migration,  although  Gambierdiscus  spp.  is  absent  from  these  areas. 
Extrapolation of this model to the Mediterranean and Macaronesian waters suggest the importance of 
monitoring sea surface temperature in addition to Gambierdiscus spp. populations for the assessment 
of  a  possible  onset  of  ciguatera  in  the  Mediterranean  Sea  and  Macaronesia  in  relation  to  
global warming. 
4.3. EU regulation for CTXs 
The presence of marine biotoxins in seafood products is regulated in order to assess the consumer’s 
safety. European regulations enforce specific hygiene rules for food of animal origin, including toxins, 
affecting  human  health  [160].  For  CFP,  this  regulation  states  that  ―Fishery  products  containing 
biotoxins such as ciguatoxin or muscle-paralysing toxins must not be placed on the market‖. This text 
was further extended to ―ciguatoxins or other toxins dangerous to human health‖ [303]. Regulations 
EC No 853/2004 [160] and EC No 1021/2008 [303] also targets other types of ichtyosarcotoxisms 
(e.g., ―fishery products derived from poisonous fish of the following families are not placed on the 
market:  Tetraodontidae,  Molidae,  Diodontidae  and  Canthigasteridae”).  These  regulations  also 
consider marine toxins present in shellfish products and set the maximum permitted levels of some 
toxins  present  in  shellfish  products.  For  shellfish  toxins,  contrarily  to  ciguatoxins,  European 
regulations clearly indicate the reference analytical methods for their detection [304]. These official 
methods include the mouse bioassay, chromatographic methods and immunosorbant assay [304–306] 
and may open the use of LC-MS/MS and other methodologies in case of validation. In addition to the 
monitoring of biotoxins in fishing products, the presence of toxin-producing phytoplankton is also 
routinely monitored in order to fulfil European legislations [307]. 
As  previously  emphasized,  European  regulations  give  no  indication  about  a  reference  analysis 
method for CTXs, nor about regulatory safety limits in fishery products. This lack of specification 
should not be interpreted as a lack of interest, as several countries in Europe—e.g., France, The United 
Kingdom, The Netherlands—actually have territories in tropical and sub-tropical ciguatera endemic 
areas periodically affected by ciguatera. Instead, this might reflect the difficulties that laboratories 
dealing  with  ciguatera  have  encoutered  during  the  last  decades  regarding  the  definition  and 
standardization of CTX determination methods and establishment of safety limits. As for the tentative 
limits proposed by several authors cited herein [18,19,24,119,120] and the comprehensive evaluation 
of methods for CTXs detection provided in this review and elsewhere [7,19,24,119,308], we expect 
that the EU will soon favor a scientific and technical coordinated effort in order to clarify these issues. 
The European Food Safety Authority (EFSA) is currently completing a mandate to issue a scientific 
opinion  on  ciguatoxins  (Mandate  M2006-0060  on  Emerging  toxins-ciguatoxins)  in  response  to  a 
question raised by the European Commission (DG-SANCO). The mandate is expected to be completed 
by July 2010. 
Of note, within the EU, national regulations specifically addressing CFP issue do exist in some 
countries.  For  example,  some  French  overseas  departments  and  territories  are  mainly  located  in 
ciguatera endemic areas (French Polynesia, La Reunion, Martinique). The French legislation directly 
incorporated  the  European  directive,  which  is  applicable  for  products  imported  into  France  from Mar. Drugs 2010, 8 
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outside the EU and permits the import of certain marine species off a positive list [309]. In French 
Polynesia, groupers, snappers, barracuda and surgeonfish are banned for sale [310].  
4.4. A risk analysis approach to confront CFP 
The risk analysis approach is highly advisable to face CFP and establish recommendations when 
dealing with CFP and public safety. As for any other food intoxication, it is also very important that 
CFP risk analysis is coordinated by one agency or body, even if several agencies or people have to be 
involved. 
In  the  process  of  risk  analysis,  three  major  issues  should  be  addressed:  risk  assessment,  risk 
management and risk communication. Numerous reviews on CFP risk, but also addressing other CFP 
issues,  have  contributed  to  CFP  risk  assessment  [3,7,18,19,23,24,255,311,312].  Secondly,  risk 
management should propose actions aiming at the reduction of risk, mainly through the establishment 
of monitoring programs for CTX producing species and toxins in food. Risk management should also 
set-up of complementary actions intended for the mitigation of ciguatera impact, and ideally reduce the 
risk. Examples of complementary actions could include providing general guidance for consumers, 
controlling  imports  and  improving  medical  assistance.  Finally,  risk  communication  should 
complement  these  two  steps  to  modulate  ―population  behavior‖  in  ciguatera  endemic  regions  and 
improve communication with competent agencies having links with food safety and medical care. 
With this strategy in mind, one may face the difficulty of assessment and management of ciguatera 
risks and establish sounded communication policies. After these initial remarks, which constitute a 
simplification of the strategy proposed, one may get into more detail to identify key actions to establish 
a thorough program to face CFP risk analysis. 
4.4.1. CFP risk assessment 
The  different  steps  regarding  risk  assessment  should  consider  hazard  identification,  hazard 
characterization, exposure assessment and risk characterization. For CFP, efforts should concentrate on 
CTXs identification, toxicity evaluation and epidemiology.  
A recent review on ciguatera fish poisoning and its’ treatment, prevention and management [23] 
resumes the key actions to undertake, mainly through the determination of CTXs in fish, the evaluation 
of  symptoms,  collection  of  epidemiological  data  and  treatment  of  CFP.  The  authors  propose,  as 
preventive  actions,  fish  avoidance  recommendations  and  communication  strategies.  However,  in 
addition to the objective of risk identification of ciguatera in a given region, additional information is 
certainly  of  interest  for  risk  assessment  studies:  such  examples  include  the  characterization  and 
distribution of the potentially ciguatoxicogenic microalgal species, as has been  reported elsewhere 
[33], the distribution of fish populations at risk, ethnological surveys regarding local remedies and 
avoidance strategies [34]. It is therefore understandable that a systematic approach is needed regarding 
the different factors that may contribute to understanding CFP in a given area, in order to have the 
widest assessment of CFP risk. Organizing the different levels at which we may identify risk factors 
influencing CFP can contribute to facilitate this systematic approach (Table 3).  
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Table 3. CFP risk assessment. A synthetic approach for the identification of risk factors. 
Level of 
information 
Factors to be addressed 
Impact and application (examples) within and beyond 
risk assessment 
Food intoxication and social aspects 
Food 
Toxin content, unequivocal species 
identification, origin of food, traceability 
Species based risk association, hazard characterization, food 
retrievals, elaboration of safe lists, identification of irregular 
practices, fraud. 
Symptoms 
General, gastrointestinal, cardiovascular, 
neurological, time lapses, duration, intensity 
CFP diagnosis, regional characterization 
Epidemiology 
Clinical records, restaurant records, 
intoxication surveys, unreported cases, 
treatment 
Risk characterization, populations at risk, therapy 
assessment, alternative food sources, epidemiological 
survey, databases 
Food habits, 
market 
Consumer surveys, fish trade and sales, 
fishing practices 
Eating habits, exposure assessment, identify areas at risk 
Ethnology  Avoidances, remedies 
Historical learning, local palliative measures, identify 
population exposed 
Environment 
Environmental 
data 
Latitude, temperature, salinity, turbulence, 
turbidity, currents, stratification 
Microalgal distribution, ecophysiology, toxin production, 
fish distribution, fish migration, prediction of potential 
expansion 
Habitat 
Benthic structure, benthic communities, coral 
status (bleaching), anthropogenic activities 
Surface availability for Gambierdiscus growth, population 
succession 
Toxins 
Chemical structure, toxicological potency, 
toxicological factor for each CTX derivative 
Toxin characterization, hazard prediction according to toxin 
analysis, regional differences according to toxin profiles 
Microalgae 
Gambierdiscus spp. , other benthic 
dinoflagellates and microalgal species 
producing toxins, species distribution and 
population dynamics, toxin content of natural 
populations and of clone cultures 
Identification of causative toxin producer species, 
comparative approach among sites, identification of hot 
spots, temporal variations, intra-specific variation, definition 
of monitoring strategies 
Fish 
Taxonomy, toxin content, transmission, 
bioaccumulation and metabolization. Toxins: 
intra-specific variation/organs/age-size. 
Trophic level: herbivorous, carnivorous. 
Behavior: Migration 
Species identification, risk associated to species, age, size 
Species distribution 
Toxic potency, identification of indicative species 
4.4.2. CFP risk management 
Risk management is often presented in four steps, which include risk evaluation, risk management 
option  assessment,  implementation  of  management  decisions  and  monitoring  and  review  of 
management actions. As for the risk management of CFP, different countries or regions affected have 
developed  through  the  years  several  options  and  decision-making  protocols  that  are  regularly 
implemented [23]. CFP management relies on different actions (Table 4), which include having a 
sound and updated legislation, an appropriate monitoring program for the identification of toxins with 
reliable laboratory tools (focusing on fish, microalgae and environmental parameters), a good system 
for the identification, treatment and reporting of CFP cases, as well as excellent coordination and Mar. Drugs 2010, 8 
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communication between agencies implicated. The management of CFP is a response for the protection 
of both the public health and the local industry (mainly fisheries and tourism). Several important issues 
involved in CFP have to be taken in consideration. 
Table 4. CFP risk management. A synthetic approach for the identification of key levels 
where action may improve CFP risk assessment and reduce the risk and impact of CFP in a 
given area. 
Level of action  Factors to be addressed  Impact and application (examples) 
Coordination between 
implicated agencies 
Define agency to coordinate actions on CFP at regional level 
Define a common strategy for the management of CFP 
Centralization of the information and multi-lateral communication 
Optimizes reaction and preventive actions 
Reduces the impact and cost of CFP 
Legislation 
Define competent authorities 
Identify toxins addressed, including derivatives 
Define acceptable levels of toxins in food 
Official methods for toxin recognition 
CFP ranking of species or groups of fish to be avoided or 
controlled 
Responsibilities of fishermen and retailers 
Import/export policies 
Provides a framework for strategy and 
decision making and defines responsibilities 
Laboratory 
CTX standards 
Reference material 
Methodology set up and standardization 
CTX identification and quantification 
Monitoring 
Toxin content in fish with validated methods 
Fish identification 
Gambierdiscus spp. population dynamics 
Toxin content in Gambierdiscus spp. with validated methods 
Environmental data (e.g., seawater temperature) 
Optimizes the strategy for toxin recognition 
in food and the identification of fish and 
areas at risk 
Reduces CFP records 
Relation between onset of ciguatera and 
climate change 
CFP records 
Symptom diagnosis 
Confirmation of CTX in blood/plasma of patients 
Regional-based epidemiological data 
Provides morbidity statistics 
Characterizes specific regional symptoms 
Reduce misidentification of other types of 
non ciguatera ichtyosarcotoxisms 
CFP treatment 
Medical board awareness on CFP 
Definition of treatment protocols 
Availabiliity of treatments 
Reduces personal CFP symptoms 
Reduces hospitalization and economic impact 
Industry/Market/Consumer 
Define alternative food sources and avoidable bad practices 
Define own strategies to overcome CFP according to regional 
recommendations 
Report CFP intoxications 
Traceability of processed food 
Reduce CFP records 
Reduce CFP impact on health and industry 
(fisheries and tourism) 
 
The large number of fish species involved in CFP toxin transmission and the high degree of 
variability in toxin content within a given species is one of the majo r limitations for CFP monitoring. 
As a matter of fact, fish catches in CFP endemic areas are often recreational or in the hands of local Mar. Drugs 2010, 8 
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fishermen  working  independently.  This  situation  noticeably  contrasts  with  shellfish  products,  for 
which most production areas are well defined in space and information provided to the producer and 
control of the production is easier. The availability of simple, fast and reliable tests that could be 
applied efficiently for the immediate screening of all individual fish on shore or in the market still 
needs to be achieved. Indeed, most methodologies for CFP toxin determination rely on sophisticated 
protocols  which  require  long  and  elaborated  laboratory  manipulations  as  well  as  well-equipped 
laboratories.  
Moreover,  the  density  of  Gambierdiscus  spp.  populations  within  a  given  area  and  their  toxin 
production could determine the eventual risk of CFP in the area. However, the fact that the CFP toxin 
trans-vector  (i.e.,  fish)  are  mobile,  and  the  fact  that  toxin  in  fish  could  result  from  a  long-term 
accumulation, their toxin content may not be representative of the concentration of microalgae at the 
time and place where the fish was caught. It is therefore advisable to invest management efforts both in 
preventive and palliative measures.  
As a response to the onset of CFP in Europe, it will be important to take in consideration various 
issues for the efficient management of CFP. Studies related to the development of toxin detection 
techniques and to the presence, distribution and toxicity of toxin-producing species and toxic fish are 
required on a long-term basis, provided that CTX standards and CTX reference materials are made 
available. The resulting information may identify species and fishing areas with high risk of CFP. 
Epidemiological data are clear indicators of the hazards of CFP within a given area. It is therefore 
important to favor the report of CFP cases to public health professionals and to confirm the presence of 
CTXs  in  leftovers  meals,  in  order  to  facilitate  differential  diagnosis  with  other  forms  of  seafood 
poisoning or fish intoxications (ichthyosarcotoxaemias). Additional effort towards the development of 
epidemiological  studies  is  therefore  advisable.  Ethnological  studies  and  surveys  can  also  reveal 
valuable information for risk management actions and risk assessment. It is important to state that the 
geographical distribution of CFP is not only determined by the presence of G. toxicus and toxic fish, 
but also by anthropological considerations such as fishing and food habits in the population, local 
control and regulations. Surveys among the population can establish tawareness of CFP within a given 
area and bring to the surface interesting information such as the identification of the most dangerous 
fish for CFP within the area. 
As for the treatment of CFP, reported in Section 2.2, mannitol administration (as well as other 
symptomatic  and  supportive  treatments)  has  been  widely  described;  a  comprehensive  synthesis  is 
presented by Friedman et al. [23]. Administration of mannitol early after intoxication seems the most 
efficient palliative medical treatment. Medical centers in newly-affected areas should be aware of the 
risk of CFP and of the efficiency of mannitol and other treatments. Additionally, local traditional 
medicine is not to be ruled out, as it may be also effective [60,62,313]. 
4.4.3. CFP risk communication 
Risk communication strategy is a matter of serious concern: it has major impact on the different 
bodies and people involved, and influences the fate of hazards. A primary requirement regarding risk 
communication of food hazards is that the body in charge of disseminating the information regarding 
the risk has to be well acquainted with the exhaustive and updated scientific and technical information Mar. Drugs 2010, 8 
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involved. A second issue is to define the strategy(ies) of risk communication chosen, which involves 
determining several factors such as the objective for such communication, the targets and the existing 
communication tools adapted for the situation. Risk communication has to take into consideration and 
predict  the  perception  and  reaction  of  the  end-users  of  the  message:  consumers,  other  agencies, 
medical bodies, food industry, etc. 
CFP is a complex phenomenon and the risk communication strategy for CFP is far from evident 
(Table 5). On the one hand, the complex transfer of toxins through the food webs and fish species 
involved does not always allow a clear determination of which fish species should be avoided. On the 
other hand, difficulties to estimate CTX content in food on a large scale have apparently not been 
overcome by technical advances of methods. Having these two examples in mind, one may consider 
that  the  risk  communication  strategy  for  CFP  may  be  designed  considering  limitations  regarding 
technical and scientific knowledge. Since CFP may result from the introduction of ciguateric fish into 
the  market  by  numerous  people  implicated  in  fishing  and  processing  of  fish,  issues  on  risk 
communication for ciguatera - basically oriented towards avoidance of fish according to species, size 
or origin - cannot be selectively targeted. Instead, risk communication may need to be widespread to 
reach all consumers and fish traders. Informative campaigns in the population should be designed in 
order  to  improve  safer  practices  regarding  fish  food  habits  that  could  support  local  regulations. 
Information to visitors on advisable food habits, species of fish and areas at risk is also required. CFP 
risk communication on the other hand may have to be constant or iterative, avoiding the creation of a 
communication vacuum, but also having in mind the possible consequences of an amplification of risk 
perception. Ciguatera risk communication may  also be targeted selectively to agencies or specific 
bodies (retailer associations, medical staff, tourist corporations, etc.) as a preventive measure to reduce 
cases of CFP intoxications: this is especially a very important issue in non-ciguatera endemic areas 
with presence of CFP caused by ciguatoxic fish imports or people travelling to ciguatera endemic 
areas.  Selective  targeted  CFP  risk  communication  can  also  favor  transfer  of  information  among 
agencies  to  improve  CFP  risk  assessment,  such  as  obtaining  more  accurate  and  reliable 
epidemiological data. 
Table 5. CFP risk communication. 
Level of communication  Factors to be addressed  Impact and application (examples) 
Widespread 
Listing of species and areas at risk 
Listing of CFP symptoms  
Define consumers actions to take in case of CFP 
Report CFP episodes 
Report ciguatera warnings and specific instructions during episodes 
Evaluate public perception and knowledge on ciguatera 
Avoidance of fishing and marketing selected 
species of fish 
Avoidance of viscera consumption 
Favor CFP reporting by consumers 
Improve risk communication strategies 
 
Selective target 
Facilitate communication and training of administration staff, retailers, 
fishermen, travel agencies and consumers 
Listing of CFP symptoms to favor CFP reporting by medical staff 
Disseminate protocols of communication among agencies 
Facilitate transfer of information to research agencies involved in the 
study of ciguatera 
Evaluate professional perception and knowledge on ciguatera 
Reduce CFP impact  
Improve CFP epidemiological records 
Understand efficiency of CFP therapies 
Improve scientific comprehension of ciguatera 
Improve risk communication strategies Mar. Drugs 2010, 8 
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4.5. Application of risk analysis for CFP in Europe  
Risk analysis studies are elaborate, require skilled working groups and may be costly. Considering 
the current state of CFP in  Europe, one  may question the  relevance of  setting up a  risk  analysis 
program in Europe. Three pieces of evidence contribute to the unequivocal settlement of CFP as a 
health hazard in Europe: (i) reports of CFP intoxication cases in European hospital and other medical 
institutions linked to fish imported from the tropics or to travelers returning from ciguatera areas; (ii) 
presence  of  fish  containing  CTXs  in  the  Canary  Islands  and  suspicion  of  toxic  fish  in  Madeira 
archipelago;  and  (iii)  recent  reports  of  the  ciguatera-causing  dinoflagellate  Gambierdiscus  in  the 
Canary Islands and in the Mediterranean Sea (Greece).  
At this stage, it is difficult to define the current awareness of the administration in Europe regarding 
CFP, and one may postulate that European countries having territories in CFP endemic areas, such as 
France or the Netherlands, may be better acquainted. As previously outlined, European legislation 
takes into consideration CFP, but does not provide any elaborate information regarding the definition 
of toxins levels and methods for toxin determination.  
Having this evidence in hand, and being aware that it is also important not to magnify the risk 
perception associated with the consumption of fishery products, risk analysis for CFP in Europe is a 
necessity. This is particularly apparent when we take into consideration that travelling to tropical areas 
is not anecdotic and that the distribution of ciguateric fish and CTX-producing microalgae might be 
expanding  in  European  waters.  Risk  analysis  for  ciguatera  in  Europe  should  be  addressed  by 
implementing efforts proportional to the present situation, maintaining the commitment to assure an 
extensive  assessment  of  the  current  CFP  situation  in  Europe  in  order  to  correctly  define  the 
management and communication strategies that should be developed.  
It  may  be  expected  that  a  risk  analysis  study  on  CFP  to  define  detailed  risk  assessment  and 
management plans as well as establish a proportionate risk communication strategy, may be considered 
in the future. Some preliminary and basic recommendations at this stage on possible priority actions 
needed in Europe are presented: 
Preliminary needs: 
-  Favor  that  the  competent  authority  will  lead  actions  related  to  risk  analysis  for  CFP,  in 
coordination with the different agencies implicated. 
-  Identify research agencies implicated in CFP to improve risk analysis. 
-  Provide the correct framework within the EU to have competent laboratories for the analysis of 
CTXs in food. 
Risk Assessment: 
-  Systematically record possible cases of CFP with strict identification of symptoms and nature 
and origin of suspicious food.  
-  Structural  and  toxicological  characterization  of  CTXs  and  other  toxins  present  in  food  and 
microalgae associated with CFP. Pursue recognition of CTX presence in Seriola spp. in the  
NE-Atlantic and consider extending analysis to other fish located in areas with presence of 
Gambierdiscus spp. 
-  Follow  benthic  microalgal  distribution  of  hazardous  species  with  special  focus  on 
Gambierdiscus spp. Mar. Drugs 2010, 8 
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-  Evaluate exposure to CTXs. 
Risk Management: 
-  Revise current legislation on CFP and foresee the set-up of expert analysis groups to identify 
deficiencies and future needs. 
-  Establish preliminary monitoring programs in areas where CFP is present. 
-  Centralize records of CFP cases in Europe for epidemiology surveillance. 
-  Establish CFP treatment protocol(s). 
-  Work in association with food import companies, local fisheries agencies in ciguatera areas and 
tourism agencies to establish action and communication protocols. 
Risk communication 
-  Define a protocol for a widespread communication strategy to the general public to be used in 
case of a ciguatera episode. 
-  Define and implement selective communication targeted at agencies and specific bodies.  
5. Conclusions 
CFP  is  managed  according  to  national  or  regional  strategies,  often  dependent  on  the  regional 
characteristics of CFP, i.e., toxin profiles, implicated fish species, local food habits, etc. However, 
there is also a lack of consensus world-wide on several CFP issues, especially regarding the methods 
for CTX determination in food. Several factors may be responsible for the present situation: (i) lack of 
certified standards and reference material, (ii) lack of a coordinated action among laboratories, and  
(iii) frame of applicability of the method (rapid screening versus accurate and confirmatory methods). 
A worldwide coordinated action could certainly improve adopting harmonized strategies to face-up to 
CFP and especially favor the establishment of a validated reference method for CTX determination in 
food. Such a method could be be used for unequivocal identification and accurate quantification of 
CTXs and as reference for the validation of more rapid screening methods. To achieve this objective, 
obtaining  certified  standards  and  reference  material,  exchanging  samples  and  setting-up  
inter-laboratories comparative studies is needed. Possibly, LC-MS/MS is the most probable candidate 
to become the reference method for CTXs once certified standards are available, a standard operation 
procedure is validated, and the required limits of detection are guaranteed. Additionally, functional 
assays such as CBA or RBA have arisen as promising techniques for high-throughput screening of 
samples and therefore efforts should be also carried out to validate them. 
This  coordinated  action  could  also  consider  a  common  risk  analysis  strategy  to  improve  risk 
assessment,  risk  management  and  risk  communication,  in  order  to  reduce  the  impact  of  CFP 
worldwide. If one may expect that this rationale would be shared by the overall scientific community 
and managers dealing with CFP, one may conclude that the present key issue would be to identify the 
platform or forum that could lead this coordinated action. Certainly all co-authors herein would favor 
international cooperation in this matter. 
CFP, mainly distributed in tropical and subtropical areas, is already affecting regions in temperate 
latitudes such as Europe. As CFP intoxications are being reported in European hospitals, methods for 
CTX  identification  are  needed  to  confirm  these  cases.  Once  this  (these)  method(s)  are  available, 
statistics and epidemiological records regarding CFP affected people in Europe should also improve. Mar. Drugs 2010, 8 
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Field studies should also contribute toward better understanding the impact of CFP in Europe. 
Understanding the distribution of CFP toxin-producing benthic dinoflagellates and evaluating CFP 
toxins  in  fish  and  microalgae  should  allow  a  better  prediction  of  CFP  risk.  Additionally,  this 
information would contribute to hypotheses regarding the possible expansion of CFP towards northern 
latitudes as a consequence of climate change. Improving detection of CTXs and understanding CFP 
spatial  distribution  will  contribute  to  improve  the  risk  analysis  of  CFP  in  the  European  
geographical area. 
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